<?xml version="1.0" encoding="UTF-8"?>
<svg height="778.0" width="557.958" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:1.0;" d="M62.360 53.720 L545.670 53.720 "/>
  <g begin="text">
   <text y="49.34" x="62.362,66.842,71.322,74.862,77.672,82.052,85.182,87.962,92.542,96.922,100.462,104.002,105.882,110.362,115.052,117.832,123.042,125.022,127.802,133.012,138.222,141.002,143.922,148.502,153.712,156.632" svgx:width="0.45,0.45,0.35,0.28,0.44,0.31,0.28,0.46,0.44,0.35,0.35,0.19,0.45,0.47,0.28,0.52,0.2,0.28,0.52,0.52,0.28,0.29,0.46,0.52,0.29,0.28" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Poster session 2, 20 (s1) </text>
   <text y="49.34" x="530.672,535.672,540.672" svgx:width="0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">379</text>
  </g>
  <g begin="text">
   <text y="768.0" x="355.802,363.932,368.622,370.502,373.312,375.192,380.092,381.972,386.352,389.132,393.712,397.562,399.442,403.822,406.952,411.432,414.972,416.852,420.392,423.172,425.572,430.052,434.742,437.872,442.562,447.252" svgx:width="0.81,0.47,0.19,0.28,0.19,0.49,0.19,0.44,0.28,0.46,0.38,0.19,0.44,0.31,0.45,0.35,0.19,0.35,0.28,0.24,0.45,0.47,0.31,0.47,0.47,0.19" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Multiple Sclerosis Journal</text>
   <text y="768.0" x="449.132,451.912,456.912,461.912,466.912,471.912,474.102,476.882,481.882,486.882,489.072,491.852,495.082,499.662,504.662,507.892,510.672,515.672,520.672,525.672,530.672,535.672,540.672" svgx:width="0.28,0.5,0.5,0.5,0.5,0.22,0.28,0.5,0.5,0.22,0.28,0.32,0.46,0.5,0.32,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;"> 2014; 20: (S1) 285â€“496</text>
  </g>
  <g begin="text">
   <text y="768.0" x="61.186,68.896,72.746,74.936,77.126,80.976,85.246,89.516,94.306,99.306,104.306,109.206,111.396,115.776,121.296" svgx:width="0.77,0.38,0.22,0.22,0.38,0.43,0.43,0.48,0.5,0.5,0.5,0.22,0.44,0.55,0.77" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">msj.sagepub.com</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.25;" d="M62.360 501.300 L111.350 501.300 "/>
  <g begin="text">
   <text y="77.103" x="62.362,66.862,69.859,72.109,73.531,79.03,83.53,85.78,88.03,89.452,91.954,96.454,100.45,103.951,107.947,110.197,111.619,115.12,117.622,122.122,126.622,129.124,133.12,136.621,138.871,140.293,142.795,146.791,150.292,152.794,156.79,161.29,163.54,164.962,171.46,175.96,179.956,182.458,186.958,190.954,193.951,196.201,197.623,200.125,202.627,204.877,206.299,210.799,214.795,218.296,220.546,221.968,226.468,230.464,232.966,237.466,241.462,245.962,248.212,249.634,252.136,256.636,260.632,262.882,264.304,268.3,272.8,275.302,277.804,280.306,282.808,287.308,289.558,290.98,293.482,297.982" svgx:width="0.5,0.33,0.25,0.55,0.61,0.5,0.25,0.25,0.55,0.28,0.5,0.44,0.39,0.44,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.44,0.39,0.25,0.55,0.28,0.44,0.39,0.28,0.44,0.5,0.25,0.55,0.72,0.5,0.44,0.28,0.5,0.44,0.33,0.25,0.55,0.28,0.28,0.25,0.55,0.5,0.44,0.39,0.25,0.55,0.5,0.44,0.28,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">of E2, these studies tested whether it has gained the ability to </text>
   <text y="88.101" x="62.362,64.864,69.364,73.864,78.364,82.36,86.356,88.606,91.603,95.599,102.601,107.101,111.097,113.599,116.101,120.601,124.597,127.099,129.601,134.101,138.601,140.851,145.351,148.348,150.598,154.594,159.094,163.594,168.094,171.595" svgx:width="0.28,0.5,0.5,0.5,0.44,0.44,0.25,0.33,0.44,0.78,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.44,0.5,0.5,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">induce remyelination of axons </text>
   <text y="88.101" x="173.845,176.347,180.847,183.097,187.093,189.595,193.591" svgx:width="0.28,0.5,0.25,0.44,0.28,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">in vivo</text>
   <text y="88.101" x="198.091" svgx:width="0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">.</text>
   <text y="99.099" x="62.362,69.364,74.368,77.365,81.361,85.357,88.354,90.856,95.356,99.352,102.853,105.85" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="99.099" x="108.217,113.716,118.216,122.212,124.579,131.581,135.577,138.079,142.579,144.946,149.446,153.946,156.943,161.443,165.943,169.444,173.44,175.807,180.307,183.304,185.671,188.173,192.673,195.175,198.676,201.043,204.544,207.046,211.546,216.046,220.546,222.913,229.411,233.407,236.908,239.275,241.777,246.277,248.644,253.144,257.14,259.642,263.638,266.635,273.637,276.139,280.639,284.635,287.002,289.504,294.004,298.0" svgx:width="0.61,0.5,0.44,0.25,0.78,0.44,0.28,0.5,0.25,0.5,0.5,0.33,0.5,0.5,0.39,0.44,0.25,0.5,0.33,0.25,0.28,0.5,0.28,0.39,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.28,0.5,0.25,0.5,0.44,0.28,0.44,0.33,0.78,0.28,0.5,0.44,0.25,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The main purpose of this study was to determine the </text>
   <text y="110.097" x="62.362,66.358,69.193,72.19,74.692,78.688,82.684,86.68,91.18,93.43,95.662,100.162,103.159,105.409,107.641,114.139,120.637,126.64,129.637,134.137,138.637,143.137,147.637,149.887,152.137,154.369,158.365,162.865,165.115,167.347,171.343,174.844,177.346,180.343,184.843,189.343,193.339,197.839,200.089,202.321,205.318,209.314,213.31,217.306,221.806,224.308,228.808,231.805,234.055,236.287,239.284,244.783,250.786,253.783,256.033,258.265,262.261,266.761,271.261,275.761,278.263,281.764,284.266,286.516,288.766,290.998,293.5,298.0" svgx:width="0.44,0.33,0.33,0.28,0.44,0.44,0.44,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.72,0.72,0.67,0.33,0.5,0.5,0.5,0.5,0.25,0.25,0.55,0.44,0.5,0.25,0.55,0.44,0.39,0.28,0.33,0.5,0.5,0.44,0.5,0.25,0.55,0.33,0.44,0.44,0.44,0.5,0.28,0.5,0.33,0.25,0.55,0.33,0.61,0.67,0.33,0.25,0.55,0.44,0.5,0.5,0.5,0.28,0.39,0.28,0.25,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">efficacy of NDC-1308, an estrogen receptor (ER) agonist, to </text>
   <text y="121.095" x="62.362,65.359,69.355,73.855,77.851,80.353,83.35,85.816,88.318,92.818,96.814,99.28,103.78,107.776,114.778,118.774,123.274,127.27,131.77,134.236,141.238,145.738,149.734,152.236,154.738,159.238,161.704,165.205,169.705,173.701,177.697,180.199,184.699,187.165,189.667,194.167,196.633,200.629,203.095,207.595,211.591,214.093,216.595,221.095,225.091,227.593,231.589,236.089,238.555,242.551,247.051,249.553,256.555,260.551,263.053,265.519,272.521,277.021,281.521,285.517,288.019,290.485,294.985,297.982" svgx:width="0.33,0.44,0.5,0.44,0.28,0.33,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.78,0.44,0.5,0.44,0.5,0.25,0.78,0.5,0.44,0.28,0.28,0.5,0.25,0.39,0.5,0.44,0.44,0.28,0.5,0.25,0.28,0.5,0.25,0.44,0.25,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.44,0.5,0.28,0.78,0.44,0.28,0.25,0.78,0.5,0.5,0.44,0.28,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">repair the damaged myelin sheath in a validated animal model of </text>
   <text y="132.093" x="62.362,66.862,70.858,77.86,82.36,86.356,88.858,91.36,95.86,99.856,102.358,104.86,109.36,113.86,116.11,118.288,121.285,125.785,128.287,132.283,136.783,141.283,145.279,149.779,151.957,156.457,160.957,163.459,167.455,171.955,178.957,182.953,186.454,188.632,192.628,195.13,198.631,203.131,205.309,207.811,212.311,216.307,218.809,223.309,227.809,231.805,234.307,236.485,238.987,241.984,244.162,248.158,252.658,254.836,257.338,261.838,264.34,266.842,269.344,273.34,275.842,278.02,282.52,286.516,291.016,295.012" svgx:width="0.5,0.44,0.78,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.33,0.5,0.28,0.44,0.5,0.5,0.44,0.5,0.25,0.5,0.5,0.28,0.44,0.5,0.78,0.44,0.39,0.25,0.44,0.28,0.39,0.5,0.25,0.28,0.5,0.44,0.28,0.5,0.5,0.44,0.28,0.25,0.28,0.33,0.25,0.44,0.5,0.25,0.28,0.5,0.28,0.28,0.28,0.44,0.28,0.25,0.5,0.44,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">demyelination. Intended outcomes also include: i) an initial bene-</text>
   <text y="143.091" x="62.362,65.359,67.861,70.363,73.36,76.357,78.859,82.36,86.86,89.11,91.423,95.419,98.92,102.421,106.417,109.918,113.419,120.421,124.417,128.917,131.419,133.669,135.982,138.979,143.479,146.476,148.726,151.039,157.537,164.035,170.038,173.035,177.535,182.035,186.535,191.035,193.285,195.535,197.848,200.35,202.852,205.849,208.099,210.412,214.912,218.908,221.41,225.406,228.403,235.405,237.907,242.407,244.909,249.409,253.909,256.159,258.472,260.974,265.474,269.47,271.72,274.033,278.533,283.033,286.534,289.036,293.536,298.036" svgx:width="0.33,0.28,0.28,0.33,0.33,0.28,0.39,0.5,0.25,0.55,0.44,0.39,0.39,0.44,0.39,0.39,0.78,0.44,0.5,0.28,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.72,0.72,0.67,0.33,0.5,0.5,0.5,0.5,0.25,0.25,0.55,0.28,0.28,0.33,0.25,0.55,0.5,0.44,0.28,0.44,0.33,0.78,0.28,0.5,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.5,0.39,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">fit-risk assessment for NDC-1308, ii) determining the dosing </text>
   <text y="154.089" x="62.362,66.862,70.858,73.855,77.851,84.853,88.849,91.351,95.347,98.344,101.845,104.482,107.479,111.979,114.976,117.613,122.113,126.613,131.113,134.11,138.106,140.608,143.11,147.61,150.112,154.108,158.104,160.606,163.243,166.24,172.738,179.236,182.233,186.229,190.729,194.725,199.225,201.727,204.229,208.729,213.229,215.866,219.367,221.869,226.369,230.869,233.371,237.367,240.868,243.118,245.755,249.751,254.251,258.751,261.388,263.89,266.392,268.894,271.891,274.528,279.028,283.024,286.525,289.027,293.527,298.027" svgx:width="0.5,0.44,0.33,0.44,0.78,0.44,0.28,0.44,0.33,0.39,0.25,0.33,0.5,0.33,0.25,0.5,0.5,0.5,0.33,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.33,0.72,0.72,0.33,0.44,0.5,0.44,0.5,0.28,0.28,0.5,0.5,0.25,0.39,0.28,0.5,0.5,0.28,0.44,0.39,0.25,0.25,0.44,0.5,0.5,0.25,0.28,0.28,0.28,0.33,0.25,0.5,0.44,0.39,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">parameters for non-clinical IND-enabling studies, and iii) design </text>
   <text y="165.087" x="62.362,66.862,69.859,72.082,74.584,79.084,83.08,85.303,90.307,94.807,98.803,102.304,106.3,108.523,113.023,115.246,119.242,121.744,124.246,128.746,131.248,135.244,139.24,141.742,143.965,147.466,149.968,154.468,158.968,162.883,165.133,166.861,173.359,176.86,179.083,182.584,187.084,191.08,195.58,197.83,200.053,206.551,213.049,219.052,222.049,226.549,231.049,235.549,240.049,242.272,248.77,252.766,256.267,258.49,261.487,265.987,268.984,275.986,280.486,282.988,286.984,289.486,293.482,297.982" svgx:width="0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.56,0.5,0.44,0.39,0.44,0.25,0.5,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.25,0.72,0.39,0.25,0.39,0.5,0.44,0.5,0.25,0.25,0.72,0.72,0.67,0.33,0.5,0.5,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.33,0.5,0.33,0.78,0.5,0.28,0.44,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">of the Phase 1 clinical study. As such, NDC-1308 was formulated </text>
   <text y="176.085" x="62.362,65.359,69.859,72.856,74.872,77.374,81.874,84.376,88.372,92.368,94.87,97.372,101.872,106.372,108.388,112.384,116.884,121.384,123.4,127.396,130.897,134.398,138.394,141.895,145.396,149.392,153.892,155.908,158.905,163.405,166.402,168.418,170.92,173.422,176.923,178.939,182.935,187.435,189.937,192.439,194.941,197.443,201.943,203.959,206.461,210.961,212.977,215.479,219.979,224.479,228.979,232.975,236.971,238.987,241.984,245.98,252.982,257.482,261.478,263.98,266.482,270.982,274.978,277.48,279.982,284.482,288.982,290.998,293.5,298.0" svgx:width="0.33,0.5,0.33,0.25,0.28,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.44,0.39,0.39,0.44,0.39,0.39,0.44,0.5,0.25,0.33,0.5,0.33,0.25,0.28,0.28,0.39,0.25,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.5,0.5,0.44,0.44,0.25,0.33,0.44,0.78,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">for injection and assessed for its ability to induce remyelination in </text>
   <text y="187.083" x="62.362,64.864,69.364,73.36,75.61,79.606,84.106,88.606,91.603,94.105,98.101,102.601,107.101,111.097,113.347,120.349,124.849,129.349,132.85,136.846,139.096,146.098,150.598,155.098,159.094,161.596,163.846,168.346,171.343,173.593,178.093,182.089,189.091,193.591,197.587,200.089,202.591,207.091,211.087,213.589,216.091,220.591,225.091" svgx:width="0.28,0.5,0.44,0.25,0.44,0.5,0.5,0.33,0.28,0.44,0.5,0.5,0.44,0.25,0.78,0.5,0.5,0.39,0.44,0.25,0.78,0.5,0.5,0.44,0.28,0.25,0.5,0.33,0.25,0.5,0.44,0.78,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">the cuprizone mouse model of demyelination.</text>
   <text y="198.081" x="62.362,70.858,74.854,77.851,82.855,87.355,92.359,95.86,98.857" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="198.081" x="102.097,108.595,115.093,121.096,124.093,128.593,133.093,137.593,142.093,144.343,145.333,151.831,155.827,159.328,161.578,162.568,166.069,168.571,172.567,177.067,179.569,184.069,186.319,187.309,190.306,194.806,197.803,204.805,209.305,211.807,215.803,218.305,222.301,226.801,229.051,230.041,233.038,237.538,240.535,242.785,243.775,246.277,250.777,253.279,257.275,261.271,263.773,266.275,270.775,275.275,277.525,278.515,283.015,286.516,289.018,293.518,298.018" svgx:width="0.72,0.72,0.67,0.33,0.5,0.5,0.5,0.5,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.39,0.28,0.44,0.5,0.28,0.5,0.25,0.55,0.33,0.5,0.33,0.78,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.28,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.39,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">NDC-1308 was stably formulated for injection using </text>
   <text y="209.079" x="62.362,66.358,70.858,73.639,78.643,84.646,90.145,93.142,97.642,101.638,104.14,108.136,111.133,115.129,119.629,123.625,126.127,130.627,135.127,139.123,143.623,146.125,149.122,151.624,156.124,158.374,161.155,169.156,173.152,175.654,179.65,182.431,189.433,191.935,195.931,199.927,202.708,209.206,213.202,216.199,220.195,222.976,225.478,228.475,232.471,236.467,238.969,242.965,247.465,250.246,253.243,257.743,260.74,263.521,268.021,272.521,275.518,282.016,286.012,290.008,294.508,298.009" svgx:width="0.44,0.5,0.25,0.56,0.67,0.61,0.33,0.5,0.44,0.28,0.44,0.33,0.44,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.28,0.33,0.28,0.5,0.25,0.25,0.89,0.44,0.28,0.44,0.25,0.78,0.28,0.44,0.44,0.25,0.72,0.44,0.33,0.44,0.25,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.33,0.5,0.33,0.25,0.5,0.5,0.33,0.72,0.44,0.44,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">an SBE-beta-cyclodextrin. Male mice were treated for 12-weeks </text>
   <text y="220.077" x="62.362,68.86,71.362,73.864,78.364,80.614,81.766,85.762,90.262,94.762,97.759,100.261,104.257,108.757,113.257,117.253,119.503,120.655,124.651,129.151,133.651,135.901,137.053,140.05,144.046,148.546,152.542,159.544,164.044,168.04,170.542,175.042,177.292,178.444,180.946,185.446,187.696,188.848,192.844,196.84,201.34,204.841,208.837,211.087,212.239,216.739,220.735,227.737,232.237,236.233,238.735,241.237,245.737,249.733,252.235,254.737,259.237,263.737,265.987,267.139,271.639,274.636,276.886,278.038,284.536,289.036,291.538,294.04,298.036" svgx:width="0.72,0.28,0.28,0.5,0.25,0.55,0.44,0.5,0.5,0.33,0.28,0.44,0.5,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.33,0.44,0.5,0.44,0.78,0.5,0.44,0.28,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.44,0.5,0.39,0.44,0.25,0.55,0.5,0.44,0.78,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.72,0.5,0.28,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">with cuprizone and rapamycin to cause demyelination of white </text>
   <text y="231.075" x="62.362,66.358,70.858,75.358,77.419,81.919,84.916,88.912,93.412,95.473,102.475,106.471,108.973,111.475,115.471,118.468,120.529,123.526,127.522,132.022,134.524,139.024,143.524,147.025,149.086,153.586,156.583,158.644,161.146,165.646,169.642,171.703,176.203,179.2,183.196,185.698,190.198,192.448,194.347,199.846,204.346,208.342,210.403,214.903,218.899,225.901,230.401,234.397,236.899,239.401,243.901,247.897,250.399,254.395,258.895,260.956,267.958,270.46,274.456,278.452,280.513,287.011,291.007,294.004,298.0" svgx:width="0.44,0.5,0.5,0.25,0.5,0.33,0.44,0.5,0.25,0.78,0.44,0.28,0.28,0.44,0.33,0.25,0.33,0.44,0.5,0.28,0.5,0.5,0.39,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.5,0.33,0.44,0.28,0.5,0.25,0.25,0.61,0.5,0.44,0.25,0.5,0.44,0.78,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.78,0.28,0.44,0.44,0.25,0.72,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and gray matter regions of the brain. The demyelinated mice were </text>
   <text y="242.073" x="62.362,66.358,70.858,77.86,80.362,84.862,87.364,90.865,93.367,97.363,100.36,104.356,108.856,111.106,112.663,119.161,125.659,131.662,134.659,139.159,143.659,148.159,152.659,154.909,156.466,160.966,165.466,167.716,169.282,171.784,176.284,178.786,181.783,185.779,190.279,194.275,197.272,199.774,202.276,206.776,211.276,215.272,219.268,221.77,224.02,225.577,228.574,233.074,237.574,239.824,241.381,248.383,252.883,255.385,261.883,266.383,268.633,270.883,272.449,276.949,279.199,283.699,286.696,288.946,290.512,295.012,298.009" svgx:width="0.44,0.5,0.78,0.28,0.5,0.28,0.39,0.28,0.44,0.33,0.44,0.5,0.25,0.55,0.72,0.72,0.67,0.33,0.5,0.5,0.5,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.28,0.5,0.28,0.33,0.44,0.5,0.44,0.33,0.28,0.28,0.5,0.5,0.44,0.44,0.28,0.25,0.55,0.33,0.5,0.5,0.25,0.55,0.78,0.5,0.28,0.72,0.5,0.25,0.25,0.55,0.5,0.25,0.5,0.33,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">administered NDC-1308 by intraperitoneal (60 mg/Kg, q.d) or </text>
   <text y="253.071" x="62.362,65.863,70.363,74.863,78.859,83.359,85.861,89.857,94.357,98.353,102.853,107.353,110.854,113.104,113.959,116.956,121.456,125.956,128.953,133.453,137.953,140.203,141.058,148.06,152.56,155.062,161.56,166.06,168.31,170.56,171.415,175.915,178.165,180.667,182.917,187.417,189.667,192.664,194.914,195.769,198.271,202.771,205.273,209.269,213.265,215.767,218.269,222.769,227.269,230.77,233.02,233.875,236.872,241.372,244.369,246.619,247.474,251.974,254.224,255.079,259.579,262.576,264.826,265.681,270.181,272.431,273.286,279.784,283.78,287.776,292.276,295.777,298.027" svgx:width="0.39,0.5,0.5,0.44,0.5,0.28,0.44,0.5,0.44,0.5,0.5,0.39,0.25,0.55,0.33,0.5,0.5,0.33,0.5,0.5,0.25,0.55,0.78,0.5,0.28,0.72,0.5,0.25,0.25,0.55,0.5,0.25,0.28,0.25,0.5,0.25,0.33,0.25,0.55,0.28,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.25,0.55,0.72,0.44,0.44,0.5,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">subcutaneous (15-60 mg/Kg, b.i.d.) injections for 3 or 6 weeks. </text>
   <text y="264.069" x="62.362,68.365,70.867,75.367,79.867,84.367,86.293,92.791,96.787,100.288,102.214,106.21,110.71,113.212,115.714,119.71,123.706,126.208,130.204,134.704,136.63,140.626,143.128,145.054,147.556,151.552,154.549,161.551,164.053,168.553,172.549,175.051,177.553,182.053,186.553,188.479,191.476,195.976,198.973,200.899,204.895,207.397,209.899,214.399,216.901,220.897,224.893,227.395,229.321,233.317,237.817,241.813,248.815,251.317,254.818,257.32,260.317,264.817,266.743,270.739,275.239,279.235,281.737,286.237,289.738,292.24,295.741,297.991" svgx:width="0.67,0.28,0.5,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.44,0.5,0.28,0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.44,0.28,0.25,0.28,0.44,0.33,0.78,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.33,0.5,0.33,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.44,0.5,0.44,0.78,0.28,0.39,0.28,0.33,0.5,0.25,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Blood was collected at termination for clinical chemistry analysis, </text>
   <text y="275.067" x="62.362,66.358,68.86,73.36,77.86,82.36,84.367,90.865,93.367,95.869,100.369,102.376,105.373,109.369,113.869,116.866,121.366,125.866,130.366,134.362,136.864,139.366,143.866,147.862,149.869,152.371,155.368,159.364,163.36,165.862,169.363,171.37,174.367,178.867,181.864,183.871,188.371,192.367,194.869,199.369,203.869,206.371,210.871,215.371,219.286,221.536,223.543,227.539,232.039,236.539,238.546,243.046,246.043,250.039,252.541,257.041,259.048,262.045,266.041,270.541,273.043,277.543,282.043,285.544,287.551,290.548,295.048,298.045" svgx:width="0.44,0.28,0.5,0.5,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.33,0.44,0.5,0.33,0.5,0.5,0.5,0.44,0.28,0.28,0.5,0.44,0.25,0.28,0.33,0.44,0.44,0.28,0.39,0.25,0.33,0.5,0.33,0.25,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.5,0.25,0.25,0.44,0.5,0.5,0.25,0.5,0.33,0.44,0.28,0.5,0.25,0.33,0.44,0.5,0.28,0.5,0.5,0.39,0.25,0.33,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">along with reproductive tracts for pathology, and brain regions for </text>
   <text y="286.065" x="62.362,66.358,69.859,73.36,77.356,80.857,84.358,86.86,91.36,95.86,98.11,100.612,105.112,109.108,111.358,113.86,117.856,122.356,126.352,128.854,131.104,135.604,138.601,140.851,147.349,153.847,159.85,162.847,167.347,171.847,176.347,180.847,183.097,186.094,190.09,197.092,201.592,205.588,208.09,210.592,215.092,219.088,221.59,224.092,228.592,233.092" svgx:width="0.44,0.39,0.39,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.28,0.44,0.5,0.44,0.28,0.25,0.5,0.33,0.25,0.72,0.72,0.67,0.33,0.5,0.5,0.5,0.5,0.25,0.33,0.44,0.78,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">assessing the level of NDC-1308 remyelination.</text>
   <text y="297.063" x="62.362,68.86,72.856,76.357,81.361,83.863,86.86,90.361,93.358" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="297.063" x="96.742,102.745,104.995,106.129,110.629,113.626,120.124,124.12,128.116,132.616,134.866,136.0,142.498,148.996,154.999,157.996,162.496,166.996,171.496,175.996,178.246,179.38,181.882,184.879,188.875,192.871,195.373,202.375,206.371,210.871,213.373,215.623,216.757,219.259,223.759,226.009,227.143,231.139,235.639,240.139,243.136,245.638,249.634,254.134,258.634,262.63,264.88,266.014,270.514,274.51,281.512,286.012,290.008,292.51,295.012" svgx:width="0.72,0.25,0.55,0.5,0.33,0.72,0.44,0.44,0.5,0.25,0.55,0.72,0.72,0.67,0.33,0.5,0.5,0.5,0.5,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.5,0.5,0.33,0.28,0.44,0.5,0.5,0.44,0.25,0.55,0.5,0.44,0.78,0.5,0.44,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">A 3-week NDC-1308 treatment in cuprizone demyeli-</text>
   <text y="308.061" x="62.362,66.862,70.858,73.36,77.356,81.856,84.25,91.252,93.754,97.75,101.746,104.14,107.137,111.133,114.634,119.134,121.636,124.138,128.134,132.634,135.028,137.53,142.03,144.424,148.924,151.921,155.917,159.913,162.415,166.411,169.408,171.802,174.304,178.804,182.8,187.3,189.694,194.194,198.694,206.191,208.585" svgx:width="0.5,0.44,0.28,0.44,0.5,0.25,0.78,0.28,0.44,0.44,0.25,0.33,0.44,0.39,0.5,0.28,0.28,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.33,0.44,0.44,0.28,0.44,0.33,0.25,0.28,0.5,0.44,0.5,0.25,0.5,0.5,0.83,0.25,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">nated mice resulted in greater than 20% (</text>
   <text y="308.061" x="211.582" svgx:width="0.61" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">P</text>
   <text y="308.061" x="217.081,222.157,224.551,229.051,231.301,235.801,240.301,244.801,247.798,250.192,254.188,258.688,263.188,265.582,270.082,274.582,282.079,284.473" svgx:width="0.56,0.25,0.5,0.25,0.5,0.5,0.5,0.33,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.83,0.25,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">&lt; 0.005) and 16% (</text>
   <text y="308.061" x="287.47" svgx:width="0.61" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">P</text>
   <text y="308.061" x="292.969,298.045" svgx:width="0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">&lt; </text>
   <text y="319.059" x="62.362,66.862,69.112,73.612,78.112,81.109,83.71,86.707,90.703,97.705,102.205,106.201,108.703,111.205,115.705,119.701,122.203,124.705,129.205,133.705,136.306,140.806,143.803,146.404,150.4,154.9,157.897,160.399,162.901,166.897,170.893,173.395,175.996,179.992,184.492,188.992,191.593,196.093,198.595,203.095,207.595,212.095,216.091,220.087,227.089,231.589,235.585,238.087,240.688,243.685,247.681,252.181,254.683,259.183,263.683,267.184,269.434,272.035,275.032,279.028,282.529,287.029,291.025,295.021" svgx:width="0.5,0.25,0.5,0.5,0.33,0.25,0.33,0.44,0.78,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.44,0.5,0.33,0.28,0.28,0.44,0.44,0.28,0.25,0.44,0.5,0.5,0.25,0.5,0.28,0.5,0.5,0.5,0.44,0.44,0.78,0.5,0.44,0.28,0.25,0.33,0.44,0.5,0.28,0.5,0.5,0.39,0.25,0.25,0.33,0.44,0.39,0.5,0.44,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">0.05) remyelination of cortical and hippocampal regions, respec-</text>
   <text y="330.057" x="62.362,64.864,67.366,71.866,75.862,78.364,82.279,84.529,86.563,93.061,95.563,98.092,102.592,105.121,111.619,115.615,119.611,124.111,127.612,130.141,134.641,137.638,140.167,146.665,153.163,159.166,162.163,166.663,171.163,175.663,180.163,182.692,185.194,188.191,192.187,196.183,198.685,205.687,209.683,214.183,216.685,218.935,221.464,224.461,228.457,235.459,239.959,243.955,246.457,248.959,253.459,257.455,259.957,262.459,266.959,271.459,273.988,276.49,280.99,283.519,288.019,290.521,295.021" svgx:width="0.28,0.28,0.5,0.44,0.28,0.5,0.25,0.25,0.72,0.28,0.25,0.5,0.25,0.72,0.44,0.44,0.5,0.39,0.25,0.5,0.33,0.25,0.72,0.72,0.67,0.33,0.5,0.5,0.5,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.25,0.33,0.44,0.78,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.5,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tively. At 6 weeks of NDC-1308 treatment, remyelination in hip-</text>
   <text y="341.055" x="62.362,66.862,71.362,75.358,79.354,86.356,90.856,94.852,97.354,99.604,101.809,104.806,108.802,113.302,115.804,120.304,124.804,128.305,130.555,132.76,135.262,139.762,143.758,146.755,150.751,154.747,158.248,162.244,166.744,168.994,171.199,173.701,178.201,180.451,182.656,187.156,191.656,199.153,201.403,203.608" svgx:width="0.5,0.5,0.44,0.44,0.78,0.5,0.44,0.28,0.25,0.55,0.33,0.44,0.5,0.28,0.5,0.5,0.39,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.5,0.83,0.25,0.55,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">pocampal regions increased to 30% (</text>
   <text y="341.055" x="206.605" svgx:width="0.61" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">P</text>
   <text y="341.055" x="212.104,217.18,219.43,221.635,226.135,228.385,232.885,237.385,241.885,246.385,249.382,251.632,253.882,256.087,261.586,266.086,268.336,270.541,275.041,277.543,282.043,284.293,286.498,290.998,295.498,298.0" svgx:width="0.56,0.25,0.55,0.5,0.25,0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.55,0.61,0.5,0.25,0.55,0.5,0.28,0.5,0.25,0.55,0.5,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">&lt; 0.0001). E2 did not </text>
   <text y="352.053" x="62.362,64.864,69.364,73.864,78.364,82.36,86.356,88.606,90.487,93.484,97.48,104.482,108.982,112.978,115.48,117.982,122.482,126.478,128.98,131.482,135.982,140.482,142.732,144.982,146.368,152.866,155.368,157.87,160.12,162.001,165.997,170.497,172.999,180.001,183.997,186.499,190.0,192.25,194.131,196.633,201.133,203.635,207.631,210.628,214.624,217.126,221.122,225.622,227.872,229.753,232.255,236.755,240.751,243.001,244.882,248.878,253.378,256.375,260.875,265.375,267.877,271.873,274.123,276.004,282.502,289.0,295.003" svgx:width="0.28,0.5,0.5,0.5,0.44,0.44,0.25,0.55,0.33,0.44,0.78,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.72,0.28,0.28,0.25,0.55,0.44,0.5,0.28,0.78,0.44,0.28,0.39,0.25,0.55,0.28,0.5,0.28,0.44,0.33,0.44,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.33,0.5,0.5,0.28,0.44,0.25,0.55,0.72,0.72,0.67,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">induce remyelination. All animals tolerated the chronic NDC-</text>
   <text y="363.051" x="62.362,66.862,71.362,75.862,80.362,82.612,84.997,87.499,90.496,94.492,98.488,100.99,107.992,111.988,116.488,118.99,122.491,124.741,127.126,133.624,137.62,140.122,142.624,144.874,147.124,149.509,156.007,160.507,164.008,168.004,171.001,175.501,179.497,183.997,186.247,188.632,192.628,197.128,199.63,206.632,210.628,213.13,215.38,217.765,222.265,226.261,230.761,234.757,239.257,241.759,246.259,249.256,251.506,253.891,257.887,262.387,266.887,269.137,271.522,275.518,278.02,280.522,285.022,287.524,291.52,295.516,298.018" svgx:width="0.5,0.5,0.5,0.5,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.44,0.28,0.28,0.25,0.25,0.55,0.72,0.5,0.39,0.44,0.33,0.5,0.44,0.5,0.25,0.55,0.44,0.5,0.28,0.78,0.44,0.28,0.25,0.55,0.5,0.44,0.5,0.44,0.5,0.28,0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">1308 treatments well. Observed animal behavior and clinical </text>
   <text y="374.049" x="62.362,66.358,70.858,74.854,81.856,84.358,87.859,90.361,93.358,95.86,99.856,103.357,105.607,106.3,112.798,116.794,119.791,123.787,126.037,126.73,131.23,135.73,138.727,145.729,149.725,152.227,154.477,156.727,157.42,161.416,165.916,170.416,172.666,173.359,175.861,180.361,184.357,187.354,191.35,193.6,194.293,200.791,204.787,208.288,210.538,211.231,215.731,220.231,222.481,223.174,227.17,231.67,234.172,238.672,242.668,247.168,251.164,255.16,257.40999999999997,258.103,262.603,265.6,267.85,268.543,272.539,277.039,281.035,284.032,287.029,291.025,295.525,298.027" svgx:width="0.44,0.5,0.44,0.78,0.28,0.39,0.28,0.33,0.28,0.44,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.5,0.5,0.33,0.78,0.44,0.28,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.5,0.5,0.25,0.55,0.44,0.5,0.28,0.5,0.44,0.5,0.44,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.5,0.44,0.33,0.33,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">chemistries were normal, and there was no evidence of aberrant </text>
   <text y="385.047" x="62.362,69.364,73.36,80.362,87.364,91.36,94.357,98.857,101.107,103.609,106.111,109.612,113.113,117.613,121.609" svgx:width="0.78,0.44,0.78,0.78,0.44,0.33,0.5,0.25,0.28,0.28,0.39,0.39,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">mammary tissue.</text>
   <text y="396.045" x="62.362,68.86,73.36,78.364,82.36,84.862,89.866,93.367,95.869,100.369,105.373,108.874,111.871" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="396.045" x="115.642,121.141,125.641,129.637,133.138,137.134,139.384,140.905,143.902,147.898,151.399,155.899,158.401,160.903,164.404,166.654,168.175,171.676,176.176,180.676,185.176,189.172,192.673,195.175,197.425,198.946,201.448,205.948,209.944,212.941,216.937,219.187,220.708,227.71,231.706,236.206,238.456,239.977,244.477,248.473,250.723,252.244,256.24,258.49,260.011,263.512,266.014,270.514,275.014,277.516,280.513,283.015,287.011,291.007,295.507,298.009" svgx:width="0.61,0.5,0.44,0.39,0.44,0.25,0.55,0.33,0.44,0.39,0.5,0.28,0.28,0.39,0.25,0.55,0.39,0.5,0.5,0.5,0.44,0.39,0.28,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.25,0.55,0.78,0.44,0.5,0.25,0.55,0.5,0.44,0.25,0.55,0.44,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">These results suggest there may be a significant </text>
   <text y="407.043" x="62.362,66.862,70.858,75.358,79.354,82.351,84.853,87.355,89.65,92.647,97.147,100.144,102.439,110.44,115.444,117.739,122.239,126.235,128.737,131.239,135.235,139.735,142.237,145.738,148.033,152.533,157.033,159.328,163.828,167.329,169.831,174.331,178.831,181.126,187.624,194.122,200.125,203.122,207.622,212.122,216.622,221.122,223.417,225.919,230.419,232.714,235.216,239.716,244.216,248.716,252.712,256.708,259.003,262.0,265.996,272.998,277.498,281.494,283.996,286.498,290.998,294.994" svgx:width="0.5,0.44,0.5,0.44,0.33,0.28,0.28,0.25,0.33,0.5,0.33,0.25,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.5,0.5,0.25,0.5,0.39,0.28,0.5,0.5,0.25,0.72,0.72,0.67,0.33,0.5,0.5,0.5,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.5,0.5,0.44,0.44,0.25,0.33,0.44,0.78,0.5,0.44,0.28,0.28,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">benefit for MS patients by using NDC-1308 to induce remyelina-</text>
   <text y="418.041" x="62.362,64.864,67.366,71.866,76.366,78.616,80.866,83.692,90.19,94.69,99.19,102.187,106.183,108.685,111.187,115.687,118.189,122.185,126.181,128.683,130.933,133.759,136.756,143.254,149.752,152.749,156.745,161.245,165.241,169.741,172.243,174.745,179.245,183.745,185.995,188.821,192.322,194.824,199.324,203.824,206.326,210.322,213.823,216.073,218.899,222.895,227.395,231.895,234.145,236.971,240.967,243.217,246.043,249.04,251.542,254.539,258.04,260.542,263.539,266.041,270.541,273.538,278.038,282.538,289.54,293.536,298.036" svgx:width="0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.72,0.5,0.5,0.33,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.33,0.72,0.72,0.33,0.44,0.5,0.44,0.5,0.28,0.28,0.5,0.5,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.44,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.25,0.55,0.33,0.28,0.33,0.39,0.28,0.33,0.28,0.5,0.33,0.5,0.5,0.78,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tion. Non-clinical IND-enabling studies and a first-in-human </text>
   <text y="429.039" x="62.362,67.366,71.866,75.862,79.363,83.359,85.609,90.109,92.359,95.86,98.362,102.862,107.362,111.862,114.112,118.108,121.105,125.101,127.351,131.851,134.353,138.349,142.849,147.349,151.345,155.845,158.095,161.092,165.592,168.589,170.839,175.339,179.839,184.339,188.839" svgx:width="0.56,0.5,0.44,0.39,0.44,0.25,0.5,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.44,0.33,0.44,0.25,0.5,0.28,0.44,0.5,0.5,0.44,0.5,0.25,0.33,0.5,0.33,0.25,0.5,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Phase 1 study are planned for 2015.</text>
   <text y="456.039" x="62.362,67.861,72.361,76.861" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P711</text>
   <text y="467.037" x="62.362,67.861,70.363,75.367,79.867,84.367,86.869,89.371,96.868,101.368,106.372,108.622,112.618,115.615,118.612,122.608,126.604,129.601,131.851,136.351,141.355,143.605,148.609,151.111,154.108,157.105,162.109,165.61,169.606,171.856,174.853,177.355,180.856,184.357,189.361,193.357,195.607,200.611,205.111,212.608,217.108,221.608,225.604,227.854,230.356,233.857,236.107,241.111,245.611,249.607,252.604,255.106,259.606" svgx:width="0.61,0.28,0.56,0.5,0.5,0.28,0.28,0.83,0.5,0.56,0.25,0.44,0.33,0.33,0.44,0.44,0.33,0.25,0.5,0.56,0.25,0.56,0.28,0.33,0.33,0.56,0.39,0.44,0.25,0.33,0.28,0.39,0.39,0.56,0.44,0.25,0.56,0.5,0.83,0.5,0.5,0.44,0.25,0.28,0.39,0.25,0.56,0.5,0.44,0.33,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Fingolimod effect on diffuse tissue damage is partly </text>
   <text y="478.035" x="62.362,64.864,69.868,74.872,78.868,83.872,87.868,92.872,97.876,101.872,106.876,109.873,112.123,116.623,119.62,121.87,124.372,127.369,130.87,133.12,137.116,140.113,143.11,147.106,151.102,154.099,156.349,160.849,165.853,168.103,171.1,175.6,179.596,184.096,186.598,188.848,193.852,198.352,205.849,210.349,214.849,218.845,221.095,223.597,228.601,230.851,234.847,238.843,241.345,245.845,250.849,254.35,256.852,261.856,266.356" svgx:width="0.28,0.56,0.56,0.44,0.56,0.44,0.56,0.56,0.44,0.56,0.33,0.25,0.5,0.33,0.25,0.28,0.33,0.39,0.25,0.44,0.33,0.33,0.44,0.44,0.33,0.25,0.5,0.56,0.25,0.33,0.5,0.44,0.5,0.28,0.25,0.56,0.5,0.83,0.5,0.5,0.44,0.25,0.28,0.56,0.25,0.44,0.44,0.28,0.5,0.56,0.39,0.28,0.56,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">independent of its effect on focal damage in relapsing-</text>
   <text y="489.033" x="62.362,66.358,70.354,77.851,80.353,83.35,86.347,88.849,93.853,98.353,100.603,108.1,113.104,115.606,118.603,121.105,126.109,128.611,132.607,134.857,138.358,142.354,144.856,148.852,152.848,157.348,160.849,163.351,166.852,169.102,174.106,178.606,181.603,184.105,188.101,193.105,196.102" svgx:width="0.44,0.44,0.83,0.28,0.33,0.33,0.28,0.56,0.5,0.25,0.83,0.56,0.28,0.33,0.28,0.56,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.44,0.5,0.39,0.28,0.39,0.25,0.56,0.5,0.33,0.28,0.44,0.56,0.33,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">remitting multiple sclerosis patients</text>
   <text y="500.031" x="62.362,68.86,71.11,77.608,81.604,83.854,88.858,91.36,95.356,98.353,102.349,106.849" svgx:width="0.72,0.25,0.72,0.44,0.25,0.56,0.28,0.44,0.33,0.44,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">N De Stefano</text>
   <text y="497.583" x="111.348" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="500.103" x="114.273,116.523,118.773,124.272,126.522,133.02,137.016,141.516,146.016,150.516" svgx:width="0.25,0.25,0.61,0.25,0.72,0.44,0.5,0.5,0.5,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, L Kappos</text>
   <text y="497.583" x="154.017" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="500.103" x="156.942,159.192,161.442,166.941,175.437,177.687,183.69,187.686,192.186,196.686" svgx:width="0.25,0.25,0.61,0.94,0.25,0.67,0.44,0.5,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, EW Radue</text>
   <text y="497.583" x="200.682" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="500.103" x="203.607,205.857,208.107,213.605,215.855,220.859,225.359,228.356,232.352,236.852,241.352,245.348" svgx:width="0.25,0.25,0.61,0.25,0.56,0.5,0.33,0.44,0.5,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, T Sprenger</text>
   <text y="497.583" x="248.345,251.27,252.732" svgx:width="0.5,0.25,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2,3</text>
   <text y="500.103" x="255.658,257.908,260.158,266.655" svgx:width="0.25,0.25,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, D </text>
   <text y="511.101" x="62.365,67.368,69.87,73.867,78.367,80.868,83.118,91.119,95.116,97.618,101.614" svgx:width="0.56,0.28,0.44,0.5,0.28,0.25,0.89,0.44,0.28,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Piani Meier</text>
   <text y="508.583" x="104.608" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">4</text>
   <text y="511.103" x="107.533,109.783,112.033,118.531,120.781,127.279,131.275,134.272,136.774,141.274" svgx:width="0.25,0.25,0.72,0.25,0.72,0.44,0.33,0.28,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, D HÃ¤ring</text>
   <text y="508.583" x="145.773" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">4</text>
   <text y="511.103" x="148.698,150.948,153.198,159.696,161.946,167.445,171.945,178.947,181.449" svgx:width="0.25,0.25,0.72,0.25,0.61,0.5,0.78,0.28,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, D Tomic</text>
   <text y="508.583" x="185.445" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">4</text>
   <text y="511.103" x="188.37,190.62,192.87,200.871,205.875,208.125,213.129,217.629,220.626,227.628,231.624,236.124" svgx:width="0.25,0.25,0.89,0.56,0.25,0.56,0.5,0.33,0.78,0.44,0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, MP Sormani</text>
   <text y="508.583" x="238.626" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">5</text>
   <text y="519.581" x="62.365" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="522.103" x="65.287,71.785,76.285,78.787,82.783,86.779,90.28,93.781,96.283,98.785,102.781,105.031,109.531,112.033,114.283,118.783,121.285,125.281,129.781,134.281,136.531,138.781,143.281,145.783,149.779,154.279,158.779,161.029,163.279,166.276,168.778,173.278,175.78,179.776,182.026" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.5,0.28,0.25,0.5,0.28,0.44,0.5,0.5,0.25,0.25,0.5,0.28,0.44,0.5,0.5,0.25,0.25,0.33,0.28,0.5,0.28,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University of Siena, Siena, Italy, </text>
   <text y="519.583" x="184.275" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="522.103" x="187.2,193.698,198.198,200.7,204.696,208.692,212.193,215.694,218.196,220.698,224.694,226.944,233.442,237.942,241.443,245.943,248.445,250.947,255.447,257.949,260.199" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.72,0.5,0.39,0.5,0.28,0.28,0.5,0.28,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University Hospital, </text>
   <text y="533.101" x="62.361,68.859,72.855,77.355,81.855,85.356,87.858,94.356,98.352,102.852,105.354,107.604,112.104,114.606,116.856,122.859,126.855,131.355,134.856,139.356,141.858,146.358,150.858,154.854,157.104,159.354,164.853,169.353,172.854,176.85,179.352,181.602,183.852,188.352,194.355,196.857,199.359,202.86,206.856,210.357,212.859,217.359,221.859,226.359,228.609" svgx:width="0.72,0.44,0.5,0.5,0.39,0.28,0.72,0.44,0.5,0.28,0.25,0.5,0.28,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.25,0.61,0.5,0.39,0.44,0.28,0.25,0.25,0.5,0.67,0.28,0.28,0.39,0.44,0.39,0.28,0.5,0.5,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Department of Neurology, Basel, Switzerland, </text>
   <text y="530.583" x="230.859" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">3</text>
   <text y="533.103" x="233.784,241.281,245.277,249.777,252.279,256.275,260.775,263.277" svgx:width="0.83,0.44,0.5,0.28,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Medical </text>
   <text y="544.101" x="62.361,65.358,71.856,76.356,80.856,84.852,87.102,92.601,97.101,101.601,104.103,108.099,111.6,114.102,117.603,119.853,125.856,129.852,134.352,136.854,140.85,144.351,146.601,149.598,157.095,160.092,165.591,171.594,174.591,176.841,179.091,185.589,190.089,192.591,196.587,200.583,204.084,207.585,210.087,212.589,216.585,218.835,225.333,229.833,233.334,237.834,240.336,242.838,247.338,249.84,252.09,254.34,259.839,264.339,267.84,271.836,274.338,276.588" svgx:width="0.33,0.72,0.5,0.5,0.44,0.25,0.61,0.5,0.5,0.28,0.44,0.39,0.28,0.39,0.25,0.67,0.44,0.5,0.28,0.44,0.39,0.25,0.33,0.83,0.33,0.61,0.67,0.33,0.25,0.25,0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.72,0.5,0.39,0.5,0.28,0.28,0.5,0.28,0.25,0.25,0.61,0.5,0.39,0.44,0.28,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Image Analysis Center (MIAC), University Hospital, Basel, </text>
   <text y="555.099" x="62.361,66.861,72.864,75.366,77.868,81.369,85.365,88.866,91.368,95.868,100.368,104.868,107.118" svgx:width="0.5,0.67,0.28,0.28,0.39,0.44,0.39,0.28,0.5,0.5,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Switzerland, </text>
   <text y="552.583" x="109.369" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">4</text>
   <text y="555.103" x="112.294,118.297,122.797,126.793,131.293,134.794,137.296,139.798,143.299,145.549,151.048,155.548,160.048,163.549,170.047,174.547,176.797,182.296,188.794,191.044,193.294,198.793,203.293,206.794,210.79,213.292,215.542,217.792,222.292,228.295,230.797,233.299,236.8,240.796,244.297,246.799,251.299,255.799,260.299,262.549" svgx:width="0.67,0.5,0.44,0.5,0.39,0.28,0.28,0.39,0.25,0.61,0.5,0.5,0.39,0.72,0.5,0.25,0.61,0.72,0.25,0.25,0.61,0.5,0.39,0.44,0.28,0.25,0.25,0.5,0.67,0.28,0.28,0.39,0.44,0.39,0.28,0.5,0.5,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Novartis Pharma AG, Basel, Switzerland, </text>
   <text y="563.583" x="62.362" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">5</text>
   <text y="566.103" x="65.287,71.785,76.285,78.787,82.783,86.779,90.28,93.781,96.283,98.785,102.781,105.031,109.531,112.033,114.283,120.781,124.777,129.277,133.777,138.277,140.527,142.777,149.275,153.271,157.771,162.271,166.771,169.021,171.271,174.268,176.77,181.27,183.772" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.5,0.28,0.25,0.72,0.44,0.5,0.5,0.5,0.25,0.25,0.72,0.44,0.5,0.5,0.5,0.25,0.25,0.33,0.28,0.5,0.28,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University of Genoa, Genoa, Italy</text>
   <text y="593.103" x="62.362,68.275,72.685,76.591,81.505,85.915,89.659,94.069,98.983,103.897,108.811,111.718" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="593.103" x="116.65,122.563,126.973,133.885,138.295,142.201,144.613,147.025,149.437,153.847,158.257,160.507,163.189,167.095,171.505,173.917,178.327,182.233,186.643,190.549,194.455,196.705,199.387,201.799,206.209,210.619,213.031,216.937,220.843,223.255,227.161,230.572,232.822,235.504,239.914,244.324,246.736,251.146,253.396,256.078,260.488,262.9,265.645,268.552,272.962,276.373,280.279,282.529,285.211,289.117,293.527,298.027" svgx:width="0.67,0.5,0.78,0.5,0.44,0.28,0.28,0.28,0.5,0.5,0.25,0.55,0.44,0.5,0.28,0.5,0.44,0.5,0.44,0.44,0.25,0.55,0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.44,0.39,0.25,0.55,0.5,0.5,0.28,0.5,0.25,0.55,0.5,0.28,0.33,0.33,0.5,0.39,0.44,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Compelling evidence indicates both diffuse and </text>
   <text y="604.101" x="62.362,65.269,69.679,73.585,77.491,79.903,82.387,84.799,87.211,90.622,94.033,98.443,102.349,104.833,109.243,113.149,120.061,123.967,128.377,132.283,134.767,138.673,143.083,146.989,151.399,153.811,157.222,159.634,162.118,164.53,168.94,171.424,173.836,178.246,182.152,184.636,189.046,191.953,195.859,198.271,202.681,205.165,209.575,212.482,214.966,219.376,223.282,225.694,228.106,232.012,236.422,238.834,242.245,244.729,251.137,253.549,255.961,260.371,262.855,265.762,269.668,272.08,275.986,280.396,283.807,286.219,290.629,295.039" svgx:width="0.33,0.5,0.44,0.44,0.28,0.25,0.28,0.28,0.39,0.39,0.5,0.44,0.25,0.5,0.44,0.78,0.44,0.5,0.44,0.25,0.44,0.5,0.44,0.5,0.28,0.39,0.28,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.33,0.44,0.28,0.5,0.25,0.5,0.33,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.28,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">focal tissue damage coexist in the brain of patients with relapsing-</text>
   <text y="615.099" x="62.362,65.269,69.175,76.087,78.499,80.911,83.323,85.735,90.145,94.555,96.634,103.546,107.956,110.368,112.78,115.192,119.602,122.014,125.92,127.999,131.41,135.316,137.728,141.634,144.541,148.951,152.362,154.774,158.185,160.264,163.171,169.084,174.997,182.908,187.822,190.729,192.808,196.714,201.124,205.534,207.613,214.525,218.431,222.841,224.92,229.33,233.236,237.142,241.552,244.459,246.538,248.95,253.36,257.77,261.676,266.086,269.992,274.402,278.812,282.718,287.128,289.54,291.952,295.777,298.027" svgx:width="0.33,0.44,0.78,0.28,0.28,0.28,0.28,0.5,0.5,0.25,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.33,0.67,0.67,0.89,0.56,0.33,0.25,0.44,0.5,0.5,0.25,0.78,0.44,0.5,0.25,0.5,0.44,0.44,0.5,0.33,0.25,0.28,0.5,0.5,0.44,0.5,0.44,0.5,0.5,0.44,0.5,0.28,0.28,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">remitting multiple sclerosis (RRMS) and may occur independently. </text>
   <text y="626.097" x="62.362,68.77,71.182,73.927,76.834,81.244,84.655,88.561,90.856,95.266,99.172,106.084,109.99,114.4,118.306,120.601,125.011,129.421,133.831,137.737,140.644,143.056,145.468,149.374,152.785,155.08,158.986,163.396,170.308,174.718,177.13,181.036,185.446,187.741,192.151,196.057,200.467,204.373,208.783,212.689,215.596,219.502,221.914,224.326,228.736,232.642,234.937,239.347,242.254,246.664,250.57,254.476,257.887,261.298,265.204,268.615,270.775,273.07,275.482,279.892,283.798,286.21,290.62,295.03" svgx:width="0.72,0.28,0.33,0.33,0.5,0.39,0.44,0.25,0.5,0.44,0.78,0.44,0.5,0.44,0.25,0.5,0.5,0.5,0.44,0.33,0.28,0.28,0.44,0.39,0.25,0.44,0.5,0.78,0.5,0.28,0.44,0.5,0.25,0.5,0.44,0.5,0.44,0.5,0.44,0.33,0.44,0.28,0.28,0.5,0.44,0.25,0.5,0.33,0.5,0.44,0.44,0.39,0.39,0.44,0.39,0.25,0.25,0.28,0.5,0.44,0.28,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Diffuse damage underlies complex degenerative processes, includ-</text>
   <text y="637.095" x="62.362,64.774,69.184,73.594,75.799,80.209,84.115,88.525,91.432,95.842,100.252,104.158,106.57,108.775,112.681,117.091,121.501,123.706,127.612,132.022,136.432,140.842,144.748,147.16,149.365,151.777,156.187,159.598,163.009,165.169,167.374,171.28,175.69,180.1,182.305,186.211,190.117,194.527,196.732,201.142,205.048,207.253,209.665,214.075,218.485,220.897,223.804,227.71,231.616,234.028,236.44,240.85,243.055,247.465,251.875,255.781,260.191,262.603,265.015,267.922,270.334,274.24,278.65,281.062,284.968,287.173,291.583,293.995,297.991" svgx:width="0.28,0.5,0.5,0.25,0.5,0.44,0.5,0.33,0.5,0.5,0.44,0.28,0.25,0.44,0.5,0.5,0.25,0.44,0.5,0.5,0.5,0.44,0.28,0.25,0.28,0.5,0.39,0.39,0.25,0.25,0.44,0.5,0.5,0.25,0.44,0.44,0.5,0.25,0.5,0.44,0.25,0.28,0.5,0.5,0.28,0.33,0.44,0.44,0.28,0.28,0.5,0.25,0.5,0.5,0.44,0.5,0.28,0.28,0.33,0.28,0.44,0.5,0.28,0.44,0.25,0.5,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ing neuronal and axonal loss, and can be indirectly quantifiable via </text>
   <text y="648.093" x="62.362,70.273,76.186,79.093,82.0,86.41,90.316,93.223,95.635,100.045,103.951,108.361,110.323,117.235,121.141,125.047,128.458,132.868,135.775,139.681,143.092,145.054,149.464,152.371,154.333,158.743,161.155,165.565,169.975,173.881,176.293,178.255,182.665,185.572,189.478,191.89,196.3,198.262,202.672,207.082,209.494,213.904,220.816,224.722,226.684,229.591,235.504,241.912,244.819,246.979,248.941,253.855,258.265,262.171,266.077,268.489,270.451,274.861,278.767,285.679,289.585,293.995,297.991" svgx:width="0.89,0.67,0.33,0.33,0.5,0.44,0.33,0.28,0.5,0.44,0.5,0.25,0.78,0.44,0.44,0.39,0.5,0.33,0.44,0.39,0.25,0.5,0.33,0.25,0.5,0.28,0.5,0.5,0.44,0.28,0.25,0.5,0.33,0.44,0.28,0.5,0.25,0.5,0.5,0.28,0.5,0.78,0.44,0.25,0.33,0.67,0.72,0.33,0.25,0.25,0.56,0.5,0.44,0.44,0.28,0.25,0.5,0.44,0.78,0.44,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">MRI-derived measures of global brain volume (BV). Focal damage </text>
   <text y="659.091" x="62.362,69.274,73.18,77.59,79.84,80.569,83.476,87.382,90.793,95.203,97.615,100.027,102.277,103.006,105.913,108.82,113.23,120.142,122.392,123.121,125.533,129.943,132.85,135.262,139.168,146.08,152.992,156.898,159.31,161.722,166.132,170.542,172.792,173.53,177.436,181.846,186.256,188.506,189.244,196.156,200.062,204.472,206.884,209.791,213.697,217.108,219.52,221.77,222.508,226.414,229.825,232.075,232.813,240.724,246.637,249.544,251.794,252.532,256.942,259.849,263.755,266.167,270.577,272.827,273.565,275.977,279.883,283.294,285.706,290.116,294.526,298.027" svgx:width="0.78,0.44,0.5,0.25,0.55,0.33,0.44,0.39,0.5,0.28,0.28,0.25,0.55,0.33,0.33,0.5,0.78,0.25,0.55,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.78,0.44,0.5,0.28,0.33,0.44,0.39,0.28,0.25,0.55,0.44,0.39,0.25,0.55,0.89,0.67,0.33,0.25,0.55,0.5,0.33,0.44,0.28,0.5,0.25,0.55,0.28,0.44,0.39,0.28,0.5,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">may result from inflammation and manifest as MRI brain lesions </text>
   <text y="670.089" x="62.362,66.268,70.678,75.088,77.635,81.541,83.953,86.365,90.775,93.187,97.093,100.999,103.411,105.958,108.865,112.771,115.183,119.089,123.499,126.91,130.816,134.227,136.387,138.934,141.841,146.251,148.798,153.712,158.122,162.028,165.439,169.345,171.892,176.302,178.849,182.755,185.167,187.579,191.989,194.401,198.307,202.213,204.625,207.172,209.584,212.491,214.903,218.809,221.221,224.632,226.792,229.339,232.246,234.658,239.068,243.478,247.888,250.3,252.712,259.624,264.034,268.444,270.991,274.402,278.812,283.222,289.63,293.536,298.036" svgx:width="0.44,0.5,0.5,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.39,0.25,0.25,0.33,0.5,0.25,0.56,0.5,0.44,0.39,0.44,0.25,0.5,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.28,0.33,0.28,0.44,0.28,0.39,0.25,0.25,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.39,0.5,0.5,0.72,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and clinical relapses. In Phase 3 clinical trials, fingolimod showed </text>
   <text y="681.087" x="62.362,65.773,68.185,72.595,77.005,79.417,82.324,84.736,88.642,92.548,96.958,99.37,102.259,105.166,109.072,113.482,117.892,121.798,124.21,126.622,131.032,135.442,138.853,141.742,144.154,148.564,151.453,155.863,160.273,162.685,167.095,169.984,172.891,177.301,181.207,185.113,187.525,190.414,192.826,196.732,200.143,202.555,206.965,211.375,214.786,217.675,221.581,225.991,230.401,233.29,236.197,240.103,242.515,246.421,249.31,253.72,256.627,259.516,265.429,271.675,274.564,276.976,281.386,284.797,288.208,291.097,293.509,298.009" svgx:width="0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25,0.33,0.44,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.28,0.5,0.25,0.5,0.5,0.28,0.5,0.25,0.33,0.5,0.44,0.44,0.28,0.25,0.28,0.44,0.39,0.28,0.5,0.5,0.39,0.25,0.44,0.5,0.5,0.25,0.33,0.44,0.28,0.44,0.25,0.5,0.33,0.25,0.67,0.72,0.25,0.28,0.5,0.39,0.39,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">significant reductions in both focal lesions and rate of BV loss in </text>
   <text y="692.085" x="62.362,68.275,74.188,82.099,87.013,89.173,93.583,97.489,99.901,102.313,106.219,110.629,113.041,116.452,118.612,123.022,126.433,128.593,130.753,135.163,137.575,141.481,145.387,149.293,153.703,158.113,160.273,163.18,167.59,172.0,176.41,179.317,181.477,185.383,189.793,194.203,196.363,200.269,204.679,206.839,210.745,214.651,217.063,219.475,223.885,227.791,229.951,233.857,238.267,245.179,249.589,253.495,256.402,260.308,262.72,267.13,269.542" svgx:width="0.67,0.67,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.5,0.39,0.25,0.25,0.5,0.28,0.44,0.44,0.44,0.5,0.5,0.25,0.33,0.5,0.5,0.5,0.33,0.25,0.44,0.5,0.5,0.25,0.44,0.5,0.25,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.28,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">RRMS patients vs. placebo (pbo) and an active comparator.</text>
   <text y="703.083" x="62.362,69.364,74.368,77.365,81.361,85.357,88.354,90.856,95.356,99.352,102.853,105.85" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="703.083" x="108.271,113.14,117.64,120.061,122.563,127.063,131.563,135.559,139.06,141.562,144.064,148.564,152.56,155.062,159.058,161.479,163.981,166.978,169.399,171.901,176.401,180.397,182.818,186.814,189.649,192.646,196.642,200.638,203.14,206.641,209.062,213.562,216.559,218.98,221.977,224.479,228.979,233.479,237.979,240.481,242.983,249.985,254.485,258.985,261.406,265.906,268.156,272.656,275.077,282.079,286.579,289.0,293.5,298.0" svgx:width="0.61,0.5,0.25,0.28,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.44,0.28,0.44,0.25,0.28,0.33,0.25,0.28,0.5,0.44,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.39,0.25,0.5,0.33,0.25,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.5,0.25,0.5,0.25,0.78,0.5,0.25,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">To investigate if the effects of fingolimod 0.5 mg on </text>
   <text y="714.081" x="62.362,68.365,74.701,76.951,78.067,80.569,85.069,88.57,92.071,94.321,95.437,99.433,102.43,106.426,108.676,109.792,116.794,120.79,125.29,127.792,131.788,134.29,138.286,142.786,145.036,146.152,148.654,153.154,156.151,160.651,165.151,169.651,174.151,176.401,177.517,180.019,182.521,186.022,188.272,189.388,193.384,196.219,199.216,203.212,207.208,209.71,213.211,215.461,216.577,221.077,225.577,227.827,228.943,231.94,236.44,240.436,244.432,246.934,249.184,250.3,254.8,258.796,265.798,269.794,274.294,278.29,280.54,281.656,286.156,289.153,291.403,292.519,295.021,298.018" svgx:width="0.67,0.72,0.25,0.55,0.28,0.5,0.39,0.39,0.25,0.55,0.44,0.33,0.44,0.25,0.55,0.78,0.44,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.33,0.5,0.5,0.5,0.5,0.25,0.55,0.28,0.28,0.39,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.39,0.25,0.55,0.5,0.5,0.25,0.55,0.33,0.5,0.44,0.44,0.28,0.25,0.55,0.5,0.44,0.78,0.44,0.5,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">BV loss are mediated through its effects on focal damage or if </text>
   <text y="725.079" x="62.362,65.359,67.861,72.361,76.861,81.361,83.863,86.365,93.367,97.867,102.367,104.617,108.613,111.115,114.616,119.116,121.366,125.362,129.358,131.86,135.361,137.611,140.113,144.613,149.113,153.109,157.609,161.605,166.105,170.605,174.601,179.101,181.603,184.105,188.605,190.855,193.357,197.857,200.107,203.104,207.1,211.6,216.1,220.096,222.598,227.098,231.598,233.848,238.348,240.85,243.685,246.682,251.182,254.683,258.679,260.929,265.429,269.425,276.427,280.423,284.923,288.919" svgx:width="0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.44,0.28,0.39,0.5,0.25,0.44,0.44,0.28,0.39,0.25,0.28,0.5,0.5,0.44,0.5,0.44,0.5,0.5,0.44,0.5,0.28,0.28,0.5,0.25,0.28,0.5,0.25,0.33,0.44,0.5,0.5,0.44,0.28,0.5,0.5,0.25,0.5,0.28,0.33,0.33,0.5,0.39,0.44,0.25,0.5,0.44,0.78,0.44,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">fingolimod also acts independently in reducing diffuse damage.</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M310.020 446.300 L352.770 446.300 "/>
  <g begin="text">
   <text y="77.103" x="310.016,318.512,322.508,325.505,330.509,335.009,340.013,343.514,346.511" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="77.103" x="348.752,351.749,356.249,358.49,362.486,364.727,369.227,373.727,378.227,380.729,384.725,389.225,391.466,395.966,400.466,403.967,406.469,409.466,413.966,418.466,422.462,424.703,428.699,433.199,437.195,439.697,444.197,447.698,450.2,453.701,455.942,460.442,463.439,465.68,468.182,472.682,476.678,478.919,483.419,487.919,491.915,495.416,499.412,501.653,506.153,508.403,510.644,515.144,519.644,522.641,529.643,534.143,538.643,541.145,545.645" svgx:width="0.33,0.5,0.25,0.44,0.25,0.5,0.5,0.5,0.28,0.44,0.5,0.25,0.5,0.5,0.39,0.28,0.33,0.5,0.5,0.44,0.25,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.39,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.5,0.5,0.44,0.39,0.44,0.25,0.5,0.25,0.25,0.5,0.5,0.33,0.78,0.5,0.5,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">In a pooled post-hoc analysis of the phase 3, 24-month </text>
   <text y="88.101" x="310.016,313.013,321.014,324.011,326.261,328.511,332.228,336.728,341.228,345.728,350.228,352.73,356.726,359.723,364.223,366.725,369.227,373.727,378.227,380.477,382.727,386.444,389.441,393.437,397.937,402.437,406.937,413.939,416.441,420.437,424.433,428.933,431.183,433.433,437.15,442.154,448.157,453.656,459.155,465.653,472.151,480.152,485.156,487.406,491.123,494.12,500.618,505.694,510.194,514.694,519.194,523.694,526.691,528.941,532.658,536.654,541.154,545.654" svgx:width="0.33,0.89,0.33,0.25,0.25,0.55,0.5,0.5,0.5,0.5,0.28,0.44,0.33,0.5,0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.33,0.44,0.5,0.5,0.5,0.78,0.28,0.44,0.44,0.5,0.25,0.25,0.55,0.56,0.67,0.61,0.61,0.72,0.72,0.89,0.56,0.25,0.55,0.33,0.72,0.56,0.5,0.5,0.5,0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(M), double-blind, randomized, FREEDOMS (N=1272) and </text>
   <text y="99.099" x="310.016,315.02,321.023,326.522,332.021,338.519,345.017,353.018,358.022,360.758,363.755,366.752,369.488,372.485,378.983,384.059,388.559,393.059,397.559,402.059,405.056,407.792,411.293,413.795,418.295,422.795,425.297,429.293,432.794,435.044,437.78,444.278,448.274,451.01,455.006,458.507,462.008,466.004,469.505,473.006,477.002,481.502,484.238,486.74,491.24,495.236,497.972,502.472,506.468,509.465,513.461,517.457,521.957,524.459,527.195,531.695,534.692,538.688,541.19,545.69" svgx:width="0.56,0.67,0.61,0.61,0.72,0.72,0.89,0.56,0.25,0.33,0.33,0.25,0.33,0.72,0.56,0.5,0.5,0.5,0.5,0.33,0.25,0.39,0.28,0.5,0.5,0.28,0.44,0.39,0.25,0.25,0.72,0.44,0.25,0.44,0.39,0.39,0.44,0.39,0.39,0.44,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.33,0.44,0.44,0.5,0.28,0.25,0.5,0.33,0.44,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">FREEDOMS II (N=1083) studies, we assessed the percent brain </text>
   <text y="110.097" x="310.016,314.516,319.016,321.518,326.018,333.02,337.016,339.266,343.01,347.006,351.506,355.502,360.002,364.502,368.498,370.748,374.492,377.489,382.493,388.496,394.994,400.997,403.247,405.497,409.241,416.243,420.239,424.235,427.736,432.236,435.233,439.229,443.729,445.979,449.723,454.223,458.723,460.973,464.717,467.219,471.719,475.715,477.965,481.709,486.713,489.215,492.212,496.712,500.708,503.21,507.71,510.707,514.703,517.205,519.455,523.199,526.196,533.198,537.194,541.694,545.69" svgx:width="0.5,0.5,0.28,0.5,0.78,0.44,0.25,0.55,0.44,0.5,0.44,0.5,0.5,0.44,0.25,0.55,0.33,0.56,0.67,0.72,0.67,0.25,0.25,0.55,0.78,0.44,0.44,0.39,0.5,0.33,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.56,0.28,0.33,0.5,0.44,0.28,0.5,0.33,0.44,0.28,0.25,0.55,0.33,0.78,0.44,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">volume change (PBVC, measured by the Structural Image </text>
   <text y="121.095" x="310.016,315.515,320.015,324.011,326.513,331.013,335.009,337.511,340.013,344.513,349.013,351.578,356.078,359.579,362.081,366.581,371.081,373.646,380.144,384.644,387.641,394.643,398.639,401.141,403.643,407.639,411.635,414.137,416.639,421.139,425.639,428.204,432.704,435.701,437.771,444.269,446.771,449.768,454.268,458.768,463.268,467.183,469.433,471.998,477.002,479.999,485.498,491.996,498.494,501.491,504.056,508.052,510.554,513.119,521.12,525.62,530.12,532.685,536.681,541.181,545.681" svgx:width="0.61,0.5,0.44,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.39,0.28,0.5,0.5,0.25,0.72,0.5,0.33,0.78,0.44,0.28,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.72,0.28,0.33,0.5,0.5,0.5,0.5,0.25,0.25,0.56,0.33,0.61,0.72,0.72,0.33,0.25,0.44,0.28,0.25,0.89,0.5,0.5,0.25,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Evaluation using Normalization of Atrophy, SIENA) at M12 and </text>
   <text y="132.093" x="310.016,314.516,319.016,321.266,323.678,326.18,330.68,333.092,337.592,341.588,344.09,346.592,350.588,355.088,357.59,361.091,363.503,370.001,372.503,375.005,379.505,381.917,386.417,390.917,393.329,397.325,401.825,404.327,408.827,412.823,417.323,421.319,425.315,427.727,432.227,435.224,437.636,440.633,445.133,449.129,453.125,455.627,458.039,462.539,465.041,468.542,472.538,476.534,480.035,484.031,486.443,490.439,494.435,496.937,499.439,503.939,506.441,508.943,512.858,515.108,517.52,522.02,526.016,533.018,537.014,539.516,543.431,545.681" svgx:width="0.5,0.5,0.25,0.25,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.5,0.5,0.25,0.44,0.5,0.28,0.5,0.44,0.5,0.44,0.44,0.25,0.5,0.33,0.25,0.33,0.5,0.44,0.44,0.28,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.25,0.5,0.44,0.78,0.44,0.28,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">24, in patients with no evidence of focal disease activity, namely, </text>
   <text y="143.091" x="310.016,314.012,318.512,322.013,326.009,330.509,334.505,338.501,341.282,345.782,348.779,351.56,356.06,360.56,363.062,367.562,370.343,374.843,378.839,385.337,388.118,392.114,396.11,398.612,401.114,405.614,409.61,412.391,414.893,418.889,422.39,424.892,429.392,433.892,437.393,440.174,443.171,449.669,454.169,459.245,461.864,467.363,471.863,474.644,477.146,481.142,484.643,487.145,491.645,496.145,499.646,502.427,506.423,510.923,515.423,517.925,522.425,525.422,528.203,532.703,536.699,543.197" svgx:width="0.44,0.5,0.39,0.44,0.5,0.44,0.44,0.25,0.5,0.33,0.25,0.5,0.5,0.28,0.5,0.25,0.5,0.44,0.72,0.25,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.28,0.44,0.39,0.28,0.5,0.5,0.39,0.25,0.33,0.72,0.5,0.56,0.25,0.61,0.5,0.25,0.28,0.44,0.39,0.28,0.5,0.5,0.39,0.25,0.44,0.5,0.5,0.28,0.5,0.33,0.25,0.5,0.44,0.72,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">absence of both new active lesions (Gd+ T1 lesions and/or new/</text>
   <text y="154.089" x="310.016,314.012,318.512,321.014,325.01,327.845,332.345,334.847,339.347,343.847,346.403,351.902,356.402,359.12,361.622,365.618,369.119,371.621,376.121,380.621,384.122,387.119,389.837,393.833,398.333,402.833,405.551,409.547,412.049,414.551,419.051,421.553,425.549,429.545,432.047,434.765,437.762,441.758,444.26,448.256,452.756,456.257,460.253,463.754,466.004,468.227,474.23,476.948,479.945,483.941,488.441,491.438,495.434,498.935,502.436,504.938,509.438,513.938,516.656,520.652,525.152,529.148,531.65,536.15,539.651,542.153,545.654" svgx:width="0.44,0.5,0.28,0.44,0.33,0.5,0.28,0.5,0.5,0.25,0.61,0.5,0.25,0.28,0.44,0.39,0.28,0.5,0.5,0.39,0.33,0.25,0.44,0.5,0.5,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.39,0.25,0.25,0.72,0.25,0.33,0.44,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">enlarging T2 lesions) and clinical relapses. A regression analysis </text>
   <text y="165.087" x="310.016,316.514,320.51,324.011,326.261,327.35,331.85,335.846,338.843,341.84,346.34,349.337,356.339,360.335,364.835,367.085,368.174,370.676,375.176,377.426,378.515,381.017,385.517,389.513,391.763,392.852,397.352,401.852,406.352,408.854,412.85,417.35,419.6,420.689,423.191,427.691,430.193,434.189,438.689,441.191,444.188,446.69,451.19,454.187,456.689,459.686,463.682,467.678,470.18,472.43,473.519,476.516,479.513,485.012,490.511,493.508,495.758,496.847,501.347,505.847,510.347,514.847,517.349,521.345,523.847,526.349,530.849,535.349,537.599,538.688,541.19,545.69" svgx:width="0.72,0.44,0.39,0.25,0.55,0.5,0.44,0.33,0.33,0.5,0.33,0.78,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.5,0.5,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.28,0.44,0.5,0.28,0.33,0.28,0.5,0.33,0.28,0.33,0.44,0.44,0.28,0.25,0.55,0.33,0.33,0.61,0.61,0.33,0.25,0.55,0.5,0.5,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">was performed in the pooled intent-to-treat (ITT) population to </text>
   <text y="176.085" x="310.016,314.516,319.016,323.012,327.512,330.014,332.516,335.513,340.013,342.551,349.049,353.549,357.545,360.047,364.547,368.543,371.54,374.078,376.58,381.08,385.076,387.614,391.61,396.11,398.612,402.608,407.108,409.61,412.148,416.648,419.645,422.183,424.685,427.682,431.678,435.674,438.176,445.178,449.174,453.674,456.176,458.714,462.71,465.545,468.542,472.538,476.534,479.036,481.574,485.075,489.071,493.067,497.567,500.105,506.603,509.105,511.607,516.107,518.645,521.642,524.144,528.644,533.144,537.644,540.146,542.648" svgx:width="0.5,0.5,0.44,0.5,0.28,0.28,0.33,0.5,0.25,0.72,0.5,0.44,0.28,0.5,0.44,0.33,0.25,0.28,0.5,0.44,0.25,0.44,0.5,0.28,0.44,0.5,0.28,0.25,0.5,0.33,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.39,0.44,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">quantify whether the extent of treatment effect seen with fingoli-</text>
   <text y="187.083" x="310.016,317.018,321.518,326.018,328.484,332.984,336.485,338.735,341.201,345.701,350.201,354.701,357.167,359.669,364.169,366.635,369.137,373.637,377.633,380.099,384.599,389.099,393.095,396.092,400.088,402.59,405.092,407.558,412.058,416.558,421.058,425.558,428.06,432.056,434.558,437.06,441.56,446.06,448.526,451.523,456.023,460.523,464.519,469.019,471.521,476.021,479.522,482.024,486.02,490.52,492.986,499.988,504.488,508.988,512.984,515.486,518.483,520.733,523.199,529.697,534.197,538.697,541.199,545.699" svgx:width="0.78,0.5,0.5,0.25,0.5,0.39,0.25,0.25,0.5,0.5,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.5,0.44,0.33,0.44,0.28,0.28,0.25,0.5,0.5,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.33,0.5,0.5,0.44,0.5,0.28,0.5,0.39,0.28,0.44,0.5,0.25,0.78,0.5,0.5,0.44,0.28,0.33,0.25,0.25,0.72,0.5,0.5,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">mod vs. pbo in the overall population (unadjusted model), would </text>
   <text y="198.081" x="310.016,314.516,318.512,320.87,327.872,331.868,334.37,338.87,341.372,345.368,347.87,352.37,356.366,360.866,363.224,367.22,370.217,372.719,376.715,379.712,382.07,386.066,390.566,393.068,397.568,401.069,403.571,406.073,410.573,415.073,417.431,420.428,424.928,427.925,430.283,434.783,438.779,445.277,447.635,451.631,455.627,458.129,460.631,465.131,469.127,471.485,473.987,477.983,481.484,483.986,488.486,492.986,496.487,498.845,502.841,507.341,511.841,514.199,518.699,523.199,526.196,529.697,532.199,536.699,541.199,545.699" svgx:width="0.5,0.44,0.25,0.78,0.44,0.28,0.5,0.28,0.44,0.28,0.5,0.44,0.5,0.25,0.44,0.33,0.28,0.44,0.33,0.25,0.44,0.5,0.28,0.5,0.39,0.28,0.28,0.5,0.5,0.25,0.33,0.5,0.33,0.25,0.5,0.44,0.72,0.25,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.28,0.44,0.39,0.28,0.5,0.5,0.39,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.33,0.39,0.28,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">be maintained after adjusting for new active lesions and on-study </text>
   <text y="209.079" x="310.016,313.013,317.009,319.511,323.507,328.007,331.508,335.504,339.005,341.255,344.252,348.248,352.748,355.25,359.75,363.251,365.753,369.749,374.249,376.499,383.501,388.001,392.501,396.497,398.999,401.996" svgx:width="0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.39,0.25,0.33,0.44,0.5,0.28,0.5,0.39,0.28,0.44,0.5,0.25,0.78,0.5,0.5,0.44,0.28,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">relapses (adjusted model).</text>
   <text y="220.077" x="310.016,316.514,320.51,324.011,329.015,331.517,334.514,338.015,341.012" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="220.077" x="344.504,351.002,353.999,356.249,357.491,359.993,364.493,368.489,370.739,371.981,376.481,380.981,385.481,389.981,392.231,393.473,397.973,401.969,404.471,406.973,410.969,415.469,417.971,421.472,423.722,424.964,427.466,431.966,435.962,438.464,442.964,447.464,451.46,455.96,458.21,459.452,461.954,466.454,468.704,469.946,472.448,476.948,479.45,482.951,485.201,486.443,490.943,495.443,499.943,502.445,506.441,510.941,513.191,514.433,518.429,522.929,526.925,529.427,533.927,537.428,539.93,543.431,545.681" svgx:width="0.72,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.5,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.28,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.28,0.39,0.25,0.55,0.5,0.5,0.5,0.28,0.44,0.5,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Of the 1383 patients included in this pooled analysis, </text>
   <text y="231.075" x="310.016,314.516,319.016,323.516,325.766,327.521,332.021,336.017,338.519,341.021,345.017,349.517,352.019,355.52,357.77,359.525,362.522,367.022,371.522,376.022,381.098,385.598,390.098,394.598,397.1,399.35,401.105,404.102,406.604,411.104,415.604,420.104,422.606,425.108,432.11,436.61,441.11,446.186,450.686,455.186,459.686,462.683,464.933,466.688,471.188,475.184,479.684,481.934,483.689,487.685,490.187,492.437,494.192,502.193,506.693,511.193,513.443,515.198,519.194,523.694,528.194,530.444,532.199,536.699,541.199,545.699" svgx:width="0.5,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.33,0.5,0.5,0.5,0.56,0.5,0.5,0.5,0.28,0.25,0.55,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.56,0.5,0.5,0.5,0.33,0.25,0.55,0.5,0.44,0.5,0.25,0.55,0.44,0.28,0.25,0.55,0.89,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">808 patients (pbo=142; fingolimod=666) had at M12 and 573 </text>
   <text y="242.073" x="310.016,314.516,318.512,321.014,323.516,327.512,332.012,334.514,338.015,339.833,342.83,347.33,351.83,356.33,361.406,365.906,370.406,372.908,374.726,377.723,380.225,384.725,389.225,393.725,396.227,398.729,405.731,410.231,414.731,419.807,424.307,428.807,433.307,436.304,438.122,442.118,444.62,446.438,454.439,458.939,463.439,465.257,468.758,473.258,477.758,484.256,488.252,492.752,494.57,499.07,503.57,505.388,508.385,512.885,516.881,520.877,523.379,525.197,529.193,533.189,535.691,538.193,542.693" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.33,0.5,0.5,0.5,0.56,0.5,0.5,0.28,0.25,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.56,0.5,0.5,0.5,0.33,0.25,0.44,0.28,0.25,0.89,0.5,0.5,0.25,0.39,0.5,0.5,0.72,0.44,0.5,0.25,0.5,0.5,0.25,0.33,0.5,0.44,0.44,0.28,0.25,0.44,0.44,0.28,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients (pbo=79; fingolimod=494) at M24 showed no focal activ-</text>
   <text y="253.071" x="310.016,312.518,315.02,318.935,321.185,323.435,328.439,330.941,335.441,339.941,344.441,346.943,349.445,356.447,360.947,365.447,367.697,371.198,373.7,378.2,382.7,385.202,388.199,390.701,394.697,398.693,403.193,405.695,408.197,412.697,414.947,417.944,421.94,426.44,430.94,434.936,438.932,443.432,445.682,450.686,456.689,463.187,469.19,471.44,475.94,480.44,482.69,487.19,491.69,499.187,501.437,505.937,509.438,511.688,513.938,518.438,522.938,527.438,529.688,534.188,538.688,542.684,545.681" svgx:width="0.28,0.28,0.5,0.25,0.25,0.56,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.33,0.44,0.5,0.5,0.44,0.44,0.5,0.25,0.56,0.67,0.72,0.67,0.25,0.5,0.5,0.25,0.5,0.5,0.83,0.25,0.5,0.39,0.25,0.25,0.5,0.5,0.5,0.25,0.5,0.5,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ity. Fingolimod significantly reduced PBVC by 52% vs. pbo over </text>
   <text y="264.069" x="310.016,314.516,319.016,321.617,329.618,332.219,335.216,338.213,342.713,344.963,349.463,353.963,356.564,361.064,364.565,367.166,370.163,374.663,376.913,381.413,385.913,388.163,390.764,395.264,400.34,404.84,407.09,411.59,416.09,420.59,423.587,426.188,430.184,434.684,439.184,441.785,446.285,450.785,453.386,457.886,462.386,469.883,472.484,476.984,481.484,485.48,488.477,491.078,495.578,500.078,502.679,510.68,513.281,516.278,519.275,523.775,526.025,530.525,535.025,537.626,542.126,545.627" svgx:width="0.5,0.5,0.25,0.89,0.25,0.33,0.33,0.5,0.25,0.5,0.5,0.25,0.5,0.39,0.25,0.33,0.5,0.25,0.5,0.5,0.25,0.25,0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.33,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.25,0.5,0.5,0.83,0.25,0.5,0.5,0.44,0.33,0.25,0.5,0.5,0.25,0.89,0.25,0.33,0.33,0.5,0.25,0.5,0.5,0.25,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">12 M (-0.22 vs -0.46, p=0.002) and by 42% over 24 M (-0.50 vs </text>
   <text y="275.067" x="310.016,313.013,317.513,319.763,324.263,328.763,331.013,333.29,337.79,342.866,347.366,349.616,354.116,358.616,363.116,366.113,368.363,370.64,373.637,378.137,380.414,384.914,389.414,393.914,396.416,400.412,404.912,407.189,410.186,415.685,421.022,423.299,427.799,432.299,436.799,441.299,443.801,447.797,450.299,452.801,457.301,461.801,464.051,466.328,470.324,474.824,477.101,481.097,485.597,489.098,493.598,496.1,500.6,503.102,507.098,509.375,513.875,516.377,519.212,522.209,526.205,529.202,533.198,537.698,541.694,545.69" svgx:width="0.33,0.5,0.25,0.5,0.5,0.25,0.25,0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.33,0.25,0.25,0.33,0.5,0.25,0.5,0.5,0.5,0.28,0.44,0.5,0.25,0.33,0.61,0.61,0.25,0.5,0.5,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.44,0.5,0.25,0.44,0.5,0.39,0.5,0.28,0.5,0.28,0.44,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.44,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">-0.86, p=0.006). In pooled ITT population, an absolute difference </text>
   <text y="286.065" x="310.016,312.518,317.018,319.439,324.443,330.446,336.944,342.947,345.368,349.868,352.865,355.286,358.283,362.783,365.033,369.533,374.033,381.53,383.951,386.948,392.024,394.445,398.945,401.195,405.695,410.195,414.695,417.692,420.113,422.615,427.115,429.536,432.533,436.529,441.029,445.529,448.526,450.947,455.447,458.444,460.865,463.862,466.364,470.864,475.364,479.864,482.366,484.868,491.87,496.37,500.87,503.291,507.791,511.292,513.713,518.213,522.713,527.213,529.634,534.134,538.634,542.63,545.627" svgx:width="0.28,0.5,0.25,0.56,0.67,0.72,0.67,0.25,0.5,0.33,0.25,0.33,0.5,0.25,0.5,0.5,0.83,0.25,0.33,0.56,0.25,0.5,0.25,0.5,0.5,0.5,0.33,0.25,0.28,0.5,0.25,0.33,0.44,0.5,0.5,0.33,0.25,0.5,0.33,0.25,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.5,0.39,0.25,0.5,0.5,0.5,0.25,0.5,0.5,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">in PBVC of -0.49% (&lt; 0.001) in favor of fingolimod vs pbo over </text>
   <text y="297.063" x="310.016,314.516,319.016,321.491,329.492,331.967,338.465,342.461,345.962,348.437,352.937,357.437,360.938,364.934,367.931,372.431,376.427,380.927,383.402,387.398,391.898,396.398,398.873,405.371,409.367,412.868,415.343,418.844,421.346,423.848,426.35,428.852,431.327,435.323,439.823,442.325,446.825,450.821,455.321,457.823,460.298,466.796,471.296,475.292,479.792,482.267,486.263,490.763,493.265,497.765,501.266,503.768,506.27,510.77,515.27,517.745,520.742,525.242,528.239,530.714,535.214,539.21,545.708" svgx:width="0.5,0.5,0.25,0.89,0.25,0.72,0.44,0.39,0.25,0.5,0.5,0.39,0.44,0.33,0.5,0.44,0.5,0.25,0.44,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.39,0.28,0.28,0.28,0.28,0.25,0.44,0.5,0.28,0.5,0.44,0.5,0.28,0.25,0.72,0.5,0.44,0.5,0.25,0.44,0.5,0.28,0.5,0.39,0.28,0.28,0.5,0.5,0.25,0.33,0.5,0.33,0.25,0.5,0.44,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">24 M was observed and was still evident when adjusting for new </text>
   <text y="308.061" x="310.016,314.012,318.008,320.51,323.012,327.512,331.508,333.758,334.712,337.214,341.21,344.711,347.213,351.713,356.213,359.714,361.964,362.918,366.914,371.414,375.914,378.164,379.118,383.618,388.118,391.115,394.616,397.118,401.618,406.118,410.618,412.868,413.822,416.819,420.815,423.317,427.313,431.813,435.314,439.31,441.56,442.514,446.51,450.506,453.008,455.51,460.01,462.512,465.014,469.514,471.764,472.718,475.715,478.712,483.212,485.462,489.962,494.462,501.959,504.209,506.459,507.413,511.913,516.989,519.239,520.193,524.693,526.943,531.443,535.943,540.443,543.44,545.69" svgx:width="0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.28,0.44,0.39,0.28,0.5,0.5,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.5,0.33,0.39,0.28,0.5,0.5,0.5,0.25,0.55,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.25,0.55,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.55,0.33,0.33,0.5,0.25,0.5,0.5,0.83,0.25,0.25,0.55,0.5,0.56,0.25,0.55,0.5,0.25,0.5,0.5,0.5,0.33,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">active lesions and on-study relapse activity (-0.28%, p&lt; 0.001). </text>
   <text y="319.059" x="310.016,315.515,320.015,324.011,326.783,329.78,333.776,338.276,341.273,345.269,348.77,352.271,354.773,359.273,363.773,366.545,373.547,378.047,382.547,386.543,389.045,391.817,395.318,399.818,404.318,408.818,412.814,416.315,418.817,422.318,425.09,427.592,432.092,436.088,438.59,441.362,445.862,450.362,457.859,460.631,463.628,466.625,471.125,473.375,477.875,482.375,489.872,492.374,495.371,499.871,502.121,506.621,511.121,518.618,521.615,524.387,528.887,531.884,534.656,537.158,541.658,545.654" svgx:width="0.61,0.5,0.44,0.25,0.33,0.44,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.78,0.5,0.5,0.44,0.28,0.25,0.39,0.5,0.5,0.5,0.44,0.39,0.28,0.39,0.25,0.28,0.5,0.44,0.28,0.25,0.5,0.5,0.83,0.25,0.33,0.33,0.5,0.25,0.5,0.5,0.83,0.28,0.33,0.5,0.25,0.5,0.5,0.83,0.33,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The regression model suggests that 57% (-0.28%/-0.49%) of the </text>
   <text y="330.057" x="310.016,314.012,316.847,319.844,323.84,327.836,330.338,333.839,336.638,341.138,344.135,346.934,349.931,352.433,356.933,361.433,365.933,368.435,370.937,377.939,382.439,386.939,389.738,394.238,398.738,401.537,406.541,412.544,419.042,425.045,427.844,431.84,434.837,438.833,441.632,444.134,448.634,453.134,457.13,461.63,465.626,470.126,474.626,478.622,483.122,485.624,488.423,492.923,495.92,498.719,501.221,503.723,507.224,510.023,514.019,516.854,519.851,523.847,527.843,530.345,533.846,536.645,541.145,545.645" svgx:width="0.44,0.33,0.33,0.44,0.44,0.28,0.39,0.25,0.5,0.33,0.25,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.5,0.5,0.25,0.56,0.67,0.72,0.67,0.25,0.44,0.33,0.44,0.25,0.28,0.5,0.5,0.44,0.5,0.44,0.5,0.5,0.44,0.5,0.28,0.25,0.5,0.33,0.25,0.28,0.28,0.39,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.39,0.25,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">effects of fingolimod on PBVC are independent of its effects on </text>
   <text y="341.055" x="310.016,313.013,317.513,321.509,325.505,328.007,330.257,334.757,338.753,345.755,349.751,354.251,358.247" svgx:width="0.33,0.5,0.44,0.44,0.28,0.25,0.5,0.44,0.78,0.44,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">focal damage.</text>
   <text y="352.053" x="310.016,316.514,321.014,326.018,330.014,332.516,337.52,341.021,343.523,348.023,353.027,356.528,359.525" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="352.053" x="364.088,369.587,374.087,378.083,380.333,382.646,386.642,389.477,392.474,396.47,400.466,402.968,405.218,407.531,412.031,415.028,417.278,419.591,422.588,425.09,429.59,434.09,438.59,441.092,443.594,450.596,455.096,459.596,461.846,464.159,468.659,473.159,475.409,477.722,482.222,484.724,487.559,490.556,495.056,498.557,502.553,504.803,507.116,511.616,515.612,522.614,526.61,531.11,535.106,537.356,539.669,542.171,545.672" svgx:width="0.61,0.5,0.44,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.28,0.33,0.33,0.5,0.39,0.44,0.25,0.55,0.5,0.44,0.78,0.44,0.5,0.44,0.25,0.55,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The effect of fingolimod on diffuse damage is </text>
   <text y="363.051" x="310.016,314.516,318.512,321.509,324.011,326.513,331.013,333.263,334.046,336.548,341.048,345.548,349.544,354.044,358.04,362.54,367.04,371.036,375.536,378.038,380.288,381.071,385.571,388.568,390.818,391.601,394.103,396.605,400.106,402.356,403.139,405.641,408.638,412.634,416.63,419.132,426.134,430.13,434.63,437.132,439.382,440.165,444.161,446.996,449.993,453.989,457.985,460.487,462.737,463.52,468.02,472.52,474.77,475.553,478.55,483.05,487.046,491.042,493.544,495.794,496.577,501.077,505.073,512.075,516.071,520.571,524.567,526.817,529.688,535.187,539.687,542.189,545.69" svgx:width="0.5,0.44,0.33,0.28,0.28,0.5,0.25,0.55,0.28,0.5,0.5,0.44,0.5,0.44,0.5,0.5,0.44,0.5,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.28,0.39,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.55,0.5,0.5,0.25,0.55,0.33,0.5,0.44,0.44,0.28,0.25,0.55,0.5,0.44,0.78,0.44,0.5,0.44,0.25,0.25,0.61,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">partly independent of its treatment effect on focal damage. This </text>
   <text y="374.049" x="310.016,313.517,318.017,322.517,327.017,331.013,334.514,337.016,340.517,343.163,345.665,350.165,354.161,356.663,359.309,362.306,364.808,369.308,373.808,378.308,380.81,383.312,390.314,394.814,399.314,401.96,406.46,410.456,413.957,416.603,420.599,425.099,427.745,431.741,434.576,437.573,441.569,445.565,448.067,450.713,455.213,459.713,462.359,466.859,471.359,473.861,478.361,481.007,483.509,488.009,491.006,493.508,497.504,504.506,511.508,515.504,518.006,522.506,525.503,530.003,532.649,536.645,541.145,545.645" svgx:width="0.39,0.5,0.5,0.5,0.44,0.39,0.28,0.39,0.25,0.28,0.5,0.44,0.28,0.25,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.5,0.44,0.39,0.25,0.44,0.5,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.5,0.5,0.25,0.5,0.5,0.28,0.5,0.25,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">suggests that fingolimod has an effect on both inflammatory and </text>
   <text y="385.047" x="310.016,314.516,318.512,323.012,326.009,330.509,335.009,339.005,343.505,347.501,352.001,355.997,358.994,362.99,365.492,367.994,372.494,376.49,378.74,382.736,387.236,394.238,398.738,403.238,407.738,411.734,416.234,418.736,422.237,424.487,428.987,431.984,434.234,442.235,447.239" svgx:width="0.5,0.44,0.5,0.33,0.5,0.5,0.44,0.5,0.44,0.5,0.44,0.33,0.44,0.28,0.28,0.5,0.44,0.25,0.44,0.5,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.39,0.25,0.5,0.33,0.25,0.89,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">neurodegenerative components of MS.</text>
   <text y="412.047" x="310.016,315.515,320.015,324.515" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P712</text>
   <text y="423.045" x="310.016,316.514,321.518,324.515,327.017,330.014,332.264,337.268,343.271,351.767,358.265,362.765,369.263,371.513,376.013,381.017,384.014,386.516,391.52,396.02,401.024,405.524,407.774,412.274,419.771,423.767,426.269,428.771,433.271,437.267,441.767,444.764,448.76,452.261,454.511,459.515,464.015,467.012,472.016,476.516,481.016,485.012,490.016,492.518,496.514" svgx:width="0.72,0.56,0.33,0.28,0.33,0.25,0.56,0.67,0.94,0.72,0.5,0.72,0.25,0.5,0.56,0.33,0.28,0.56,0.5,0.56,0.5,0.25,0.5,0.83,0.44,0.28,0.28,0.5,0.44,0.5,0.33,0.44,0.39,0.25,0.56,0.5,0.33,0.56,0.5,0.5,0.44,0.56,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Anti- SEMA4D antibody ameliorates pathogenic </text>
   <text y="434.043" x="310.016,315.02,319.016,323.516,327.512,331.508,335.009,338.51,342.506,346.007,348.257,352.253,356.249,358.751,363.251,366.248,370.244,375.248,377.498,380.495,384.995,387.245,394.742,399.746,402.248,405.245,407.747,412.751,415.253,419.249,421.499,425.0,428.996,431.498,435.494,439.49,443.99,447.491,449.993" svgx:width="0.56,0.44,0.5,0.44,0.44,0.39,0.39,0.44,0.39,0.25,0.44,0.44,0.28,0.5,0.33,0.44,0.56,0.25,0.33,0.5,0.25,0.83,0.56,0.28,0.33,0.28,0.56,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.44,0.5,0.39,0.28,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">processes related to multiple sclerosis</text>
   <text y="445.041" x="310.016,316.514,321.518,323.768,327.269,331.769,336.269,340.265,343.766,348.266" svgx:width="0.72,0.56,0.25,0.39,0.5,0.5,0.44,0.39,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">AS Jonason</text>
   <text y="442.583" x="352.765" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="445.103" x="355.69,357.94,360.19,365.689,367.939,374.437,376.939,379.441,386.443,390.439,392.941,396.937,401.437,405.433,409.933" svgx:width="0.25,0.25,0.61,0.25,0.72,0.28,0.28,0.78,0.44,0.28,0.44,0.5,0.44,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, E Klimatcheva</text>
   <text y="442.583" x="413.929" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="445.103" x="416.854,419.104,421.354,426.853,429.103,434.107,436.609,440.11,444.61,448.606" svgx:width="0.25,0.25,0.61,0.25,0.56,0.28,0.39,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, T Fisher</text>
   <text y="442.583" x="451.602" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="445.103" x="454.527,456.777,459.027,465.03,467.28,473.283,477.279,479.781,482.283,484.785" svgx:width="0.25,0.25,0.67,0.25,0.67,0.44,0.28,0.28,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, C Reilly</text>
   <text y="442.583" x="489.285" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="445.103" x="492.21,494.46,496.71,502.209" svgx:width="0.25,0.25,0.61,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, L </text>
   <text y="456.101" x="310.014,318.51,321.012,325.512,328.014,332.01" svgx:width="0.94,0.28,0.5,0.28,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Winter</text>
   <text y="453.583" x="335.008" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="456.103" x="337.933,340.183,342.433,345.934,348.184,354.682,358.678,362.674,365.671,369.667,372.664,376.66,381.16,385.66,389.656,394.156,398.152" svgx:width="0.25,0.25,0.39,0.25,0.72,0.44,0.44,0.33,0.44,0.33,0.44,0.5,0.5,0.44,0.5,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, J Veeraraghavan</text>
   <text y="453.583" x="402.651" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="456.103" x="405.576,407.826,410.076,418.077,420.327,426.825,431.325,435.825,439.821,442.818,445.32" svgx:width="0.25,0.25,0.89,0.25,0.72,0.5,0.5,0.44,0.33,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, M Doherty</text>
   <text y="453.583" x="449.82" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="456.103" x="452.745,454.995,457.245,463.248,465.498,473.499,477.495,479.997,482.499,486.999" svgx:width="0.25,0.25,0.67,0.25,0.89,0.44,0.28,0.28,0.5,0.72" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, C Mallow</text>
   <text y="453.583" x="493.496" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="456.103" x="496.421,498.671,500.921,504.422,506.672,511.676,515.672,518.174,520.676" svgx:width="0.25,0.25,0.39,0.25,0.56,0.44,0.28,0.28,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, J Seils</text>
   <text y="453.583" x="524.177" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="456.103" x="527.102,529.352" svgx:width="0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, </text>
   <text y="467.101" x="310.013,316.511,318.761,324.764,329.264,332.765,336.266,338.768,342.764" svgx:width="0.72,0.25,0.67,0.5,0.39,0.39,0.28,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">H Bussler</text>
   <text y="464.583" x="345.763" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="467.103" x="348.688,350.938,353.188,358.192,360.442,365.941,370.441,373.438,377.938" svgx:width="0.25,0.25,0.56,0.25,0.61,0.5,0.33,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, S Torno</text>
   <text y="464.583" x="382.438" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="467.103" x="385.363,387.613,389.863,395.866,398.116,404.614,407.116,410.113" svgx:width="0.25,0.25,0.67,0.25,0.72,0.28,0.33,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, R Kirk</text>
   <text y="464.583" x="414.613" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="467.103" x="417.538,419.788,422.038,428.536,430.786,437.284,441.784,448.282,452.278,454.78" svgx:width="0.25,0.25,0.72,0.25,0.72,0.5,0.72,0.44,0.28,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, A Howell</text>
   <text y="464.583" x="457.281" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="467.103" x="460.206,462.456,464.706,472.707,474.957,479.961,483.957,486.954,489.456,493.956,497.952,502.452" svgx:width="0.25,0.25,0.89,0.25,0.56,0.44,0.33,0.28,0.5,0.44,0.5,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, M Scrivens</text>
   <text y="464.583" x="505.953" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="467.103" x="508.878,511.128,513.378,518.877" svgx:width="0.25,0.25,0.61,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, L </text>
   <text y="478.101" x="310.014,316.017,320.013,322.515,326.511" svgx:width="0.67,0.44,0.28,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Balch</text>
   <text y="475.583" x="331.012" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="478.103" x="333.937,336.187,338.437,343.936,346.186,351.19,355.186,359.686,364.186,366.688,371.188" svgx:width="0.25,0.25,0.61,0.25,0.56,0.44,0.5,0.5,0.28,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, T Pandina</text>
   <text y="475.583" x="375.184" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="478.103" x="378.109,380.359,382.609,391.105,393.355,401.851,405.847,410.347" svgx:width="0.25,0.25,0.94,0.25,0.94,0.44,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, W Wang</text>
   <text y="475.583" x="414.847" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="478.103" x="417.772,420.022,422.272,427.771,430.021,435.52,440.02,444.016,448.516" svgx:width="0.25,0.25,0.61,0.25,0.61,0.5,0.44,0.5,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, E Evans</text>
   <text y="475.583" x="452.016" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="478.103" x="454.941,457.191,459.441,467.937,471.438,473.688,479.691,484.191,490.689,494.685,497.682" svgx:width="0.25,0.25,0.94,0.39,0.25,0.67,0.5,0.72,0.44,0.33,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, WJ Bowers</text>
   <text y="475.583" x="501.183" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="478.103" x="504.108,506.358,508.608,516.609" svgx:width="0.25,0.25,0.89,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, M </text>
   <text y="489.101" x="310.014,315.018,319.014,322.011,324.513" svgx:width="0.56,0.44,0.33,0.28,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Paris</text>
   <text y="486.583" x="328.016" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="489.103" x="330.94,333.19,335.44,338.941,341.191,346.69,350.686,355.186,359.686,363.682,366.68" svgx:width="0.25,0.25,0.39,0.25,0.61,0.44,0.5,0.5,0.44,0.33,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, J Leonard</text>
   <text y="486.583" x="371.179" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="489.103" x="374.104,376.354,378.604,385.102,387.352,390.349,394.849,399.349,401.851,405.352,409.852" svgx:width="0.25,0.25,0.72,0.25,0.33,0.5,0.5,0.28,0.39,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, V Iddison</text>
   <text y="486.583" x="414.352" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="489.103" x="417.277,419.527,421.777,427.276,429.526,434.53,441.532,444.034,446.536" svgx:width="0.25,0.25,0.61,0.25,0.56,0.78,0.28,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, E Smith</text>
   <text y="486.583" x="451.036" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="489.103" x="453.961,456.211,458.461,466.462,468.712,474.211,478.207,482.707,487.207,491.203,494.2,498.196" svgx:width="0.25,0.25,0.89,0.25,0.61,0.44,0.5,0.5,0.44,0.33,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, M Zauderer</text>
   <text y="486.583" x="501.192" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="497.581" x="310.014" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="500.103" x="312.941,318.44,322.94,326.936,330.932,333.434,337.934,341.93,345.926,348.176,350.426,353.423,357.923,361.919,364.169,366.419,368.669,374.168,378.668,382.664,387.164,391.16,394.661,397.163,401.159,404.66,406.91,409.16,415.163,420.167,422.417,424.667,431.165,435.665,438.167,440.669,444.665,449.165,451.415,455.915,458.417,462.917,465.419,469.415" svgx:width="0.61,0.5,0.44,0.44,0.28,0.5,0.44,0.44,0.25,0.25,0.33,0.5,0.44,0.25,0.25,0.25,0.61,0.5,0.44,0.5,0.44,0.39,0.28,0.44,0.39,0.25,0.25,0.67,0.56,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Vaccinex, Inc., Rochester, NY, United States</text>
   <text y="527.103" x="310.016,316.064,320.609,324.65,329.699,334.244,338.123,342.668,347.717,352.766,357.815,360.857" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="527.103" x="364.196,369.245,373.286,380.333,384.374,388.919,393.464,398.009,401.051,403.598,408.143,410.393,411.482,416.027,422.57,424.82,425.909,428.951,434.0,439.544,447.59,454.133,458.678,465.221,467.768,473.816,480.359,484.904,489.449,493.994,497.036,499.286,500.375,502.922,506.468,508.718,509.807,513.848,518.393,522.938,525.98,530.021,533.567,537.113,541.154,545.654" svgx:width="0.56,0.44,0.78,0.44,0.5,0.5,0.5,0.33,0.28,0.5,0.25,0.55,0.5,0.72,0.25,0.55,0.33,0.56,0.61,0.89,0.72,0.5,0.72,0.28,0.67,0.72,0.5,0.5,0.5,0.33,0.25,0.55,0.28,0.39,0.25,0.55,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Semaphorin 4D (SEMA4D/CD100) is expressed </text>
   <text y="538.101" x="310.016,314.561,319.106,321.329,325.874,329.915,334.46,337.502,341.543,344.09,346.313,350.354,354.899,359.444,361.667,364.214,371.261,378.308,382.853,387.398,391.439,393.662,397.703,401.744,404.291,406.838,410.384,412.679,414.902,418.943,423.488,428.033,430.256,432.803,435.35,438.896,441.119,445.664,448.211,452.756,457.301,459.524,463.565,466.445,469.487,472.034,476.579,479.126,481.673,486.218,488.441,491.483,495.524,499.565,503.606,508.151,510.698,515.243,517.925,520.22,522.443,527.492,530.039,534.08,538.625,541.172,545.672" svgx:width="0.5,0.5,0.25,0.5,0.44,0.5,0.33,0.44,0.28,0.25,0.44,0.5,0.5,0.25,0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.25,0.44,0.5,0.5,0.25,0.28,0.28,0.39,0.25,0.5,0.28,0.5,0.5,0.25,0.44,0.33,0.33,0.28,0.5,0.28,0.28,0.5,0.25,0.33,0.44,0.44,0.44,0.5,0.28,0.5,0.33,0.25,0.25,0.56,0.28,0.44,0.5,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">on neural and immune cells, and its high affinity receptor, Plexin </text>
   <text y="549.099" x="310.016,316.064,320.609,322.859,323.687,326.729,331.778,337.322,343.865,350.408,356.456,361.001,364.043,366.338,368.588,369.416,371.963,375.509,377.759,378.587,382.628,387.173,391.718,394.76,398.801,402.347,405.893,409.934,414.479,416.729,417.557,422.102,426.647,428.897,429.725,434.27,438.311,442.856,447.401,450.443,452.99,455.537,458.084,462.125,464.42,466.67,467.498,471.539,476.084,480.629,485.174,487.721,492.266,496.307,498.854,501.401,505.442,507.989,510.284,512.534,513.362,517.403,521.948,526.493,528.743,529.571,534.116,538.157,542.702" svgx:width="0.67,0.5,0.25,0.55,0.33,0.56,0.61,0.72,0.72,0.67,0.5,0.33,0.25,0.25,0.55,0.28,0.39,0.25,0.55,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.44,0.5,0.5,0.33,0.28,0.28,0.28,0.44,0.25,0.25,0.55,0.44,0.5,0.5,0.5,0.28,0.5,0.44,0.28,0.28,0.44,0.28,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.44,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">B1 (PLXNB1), is expressed on dendritic, endothelial, and neu-</text>
   <text y="560.097" x="310.016,313.058,317.603,322.148,326.189,328.736,330.986,333.938,337.979,342.02,344.567,347.114,350.66,352.955,355.205,358.157,363.206,368.75,376.796,383.339,387.884,394.427,396.677,399.629,403.175,405.722,410.267,414.812,418.853,421.4,423.947,428.492,433.037,435.287,438.239,440.786,445.331,448.373,452.918,457.463,462.008,466.553,468.803,471.755,476.804,482.348,488.891,495.434,501.482,506.027,508.277,511.229,515.774,519.815,523.361,525.611,528.563,533.108,537.149,541.19,545.69" svgx:width="0.33,0.5,0.5,0.44,0.28,0.25,0.55,0.44,0.44,0.28,0.28,0.39,0.25,0.25,0.55,0.56,0.61,0.89,0.72,0.5,0.72,0.25,0.55,0.39,0.28,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.33,0.5,0.5,0.5,0.5,0.25,0.55,0.56,0.61,0.72,0.72,0.67,0.5,0.25,0.55,0.5,0.44,0.39,0.25,0.55,0.5,0.44,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ronal cells. SEMA4D signaling through PLXNB1 has been </text>
   <text y="571.095" x="310.016,313.562,318.107,322.652,329.195,333.74,335.99,337.673,340.22,344.765,347.015,348.698,355.745,360.29,364.835,369.38,371.927,375.968,378.515,382.556,384.806,386.489,391.034,393.581,396.128,400.169,402.716,404.966,406.649,410.69,414.731,417.278,419.825,422.075,423.758,427.799,431.84,434.387,436.934,441.479,445.52,448.067,450.614,455.159,459.704,461.999,464.249,465.932,468.479,473.024,477.569,480.116,484.661,487.208,489.755,492.005,493.688,498.233,500.78,503.66,506.702,510.743,513.785,517.826,522.371,524.918,527.465,531.506,534.053,536.6,541.145,545.645" svgx:width="0.39,0.5,0.5,0.72,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.78,0.5,0.5,0.5,0.28,0.44,0.28,0.44,0.25,0.55,0.5,0.28,0.28,0.44,0.28,0.25,0.55,0.44,0.44,0.28,0.28,0.25,0.55,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.28,0.5,0.5,0.28,0.5,0.28,0.28,0.25,0.55,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.28,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">shown to modulate glial cell activation, inhibit differentiation </text>
   <text y="582.093" x="310.016,314.057,318.602,323.147,325.208,332.255,334.802,339.347,342.389,346.43,348.977,351.524,356.069,360.614,362.675,367.22,370.262,372.323,376.868,379.415,381.962,386.507,391.052,395.597,399.638,404.183,408.728,411.77,416.315,420.356,424.901,427.448,431.489,433.55,438.095,441.137,445.178,449.219,453.764,456.806,460.352,464.897,467.939,470.0,474.041,478.082,480.629,483.176,486.722,488.783,491.825,498.368,503.417,509.465,513.011,516.053,518.348,520.409,524.954,527.501,531.047,534.089,538.634,543.179,545.681" svgx:width="0.44,0.5,0.5,0.25,0.78,0.28,0.5,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.5,0.28,0.28,0.5,0.5,0.5,0.44,0.5,0.5,0.33,0.5,0.44,0.5,0.28,0.44,0.25,0.5,0.33,0.44,0.44,0.5,0.33,0.39,0.5,0.33,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.33,0.72,0.56,0.67,0.39,0.33,0.25,0.25,0.5,0.28,0.39,0.33,0.5,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and migration of oligodendrocyte precursor cells (OPCs), disrupt </text>
   <text y="593.091" x="310.016,316.064,322.607,327.656,329.906,331.742,335.783,340.328,344.873,349.418,351.965,356.51,360.551,363.098,365.645,369.686,372.233,374.483,376.319,378.866,381.413,385.958,390.503,393.05,395.3,397.136,399.683,404.228,408.773,412.814,415.361,417.908,422.453,426.998,430.544,432.839,435.089,436.925,440.966,445.511,450.056,452.306,454.142,456.689,461.234,465.779,470.324,474.365,478.406,480.656,482.492,487.037,491.078,495.623,498.665,503.21,507.755,511.796,514.343,516.593,518.429,522.974,526.016,530.561,534.602,538.643,542.189,545.69" svgx:width="0.67,0.72,0.56,0.25,0.55,0.44,0.5,0.5,0.5,0.28,0.5,0.44,0.28,0.28,0.44,0.28,0.25,0.55,0.28,0.28,0.5,0.5,0.28,0.25,0.55,0.28,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.5,0.5,0.44,0.44,0.25,0.55,0.5,0.44,0.5,0.33,0.5,0.5,0.44,0.28,0.25,0.55,0.5,0.33,0.5,0.44,0.44,0.39,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CNS endothelial tight junctions, and induce neuronal process </text>
   <text y="604.089" x="310.016,314.057,318.602,321.149,323.696,327.737,332.282,335.828,339.869,342.164,344.153,352.199,356.744,359.291,361.838,364.385,368.93,371.477,375.518,377.507,381.053,385.094,387.641,391.682,394.724,399.269,402.815,405.362,408.908,410.897,413.939,421.985,427.034,430.076,432.065,434.612,438.158,440.147,444.188,446.177,450.218,454.763,457.805,462.35,466.895,469.442,473.483,475.472,480.017,484.058,488.603,491.645,496.19,498.737,503.282,506.324,508.871,512.912,519.959,527.006,531.047,533.594,538.139,541.181,545.681" svgx:width="0.44,0.5,0.28,0.28,0.44,0.5,0.39,0.44,0.25,0.25,0.89,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.33,0.89,0.56,0.33,0.25,0.28,0.39,0.25,0.44,0.25,0.44,0.5,0.33,0.5,0.5,0.28,0.44,0.25,0.5,0.44,0.5,0.33,0.5,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">collapse. Multiple sclerosis (MS) is a chronic neuroinflammatory </text>
   <text y="615.087" x="310.016,314.561,317.108,320.654,324.695,328.736,332.282,336.323,338.573,340.049,344.09,348.635,352.676,355.718,359.759,363.8,366.347,370.388,373.43,375.977,380.018,384.059,388.604,390.854,392.33,396.875,401.42,403.67,405.137,411.185,417.728,422.777,425.027,426.503,429.05,436.097,443.144,447.689,452.234,456.275,458.525,460.001,464.042,468.083,470.63,473.177,475.427,476.903,479.45,483.995,487.037,489.584,492.131,494.678,497.72,501.761,504.308,506.855,511.4,515.945,518.24,520.49,521.966,526.511,529.058,533.603,538.148,542.693" svgx:width="0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.55,0.44,0.5,0.44,0.33,0.44,0.44,0.28,0.44,0.33,0.28,0.44,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.67,0.72,0.56,0.25,0.55,0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.55,0.44,0.44,0.28,0.28,0.25,0.55,0.28,0.5,0.33,0.28,0.28,0.28,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.5,0.28,0.5,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">disease characterized by CNS immune cell infiltration, blood-</text>
   <text y="626.085" x="310.016,314.561,317.603,321.644,324.191,328.736,330.986,332.795,337.34,341.381,344.423,347.465,350.012,354.053,357.095,359.345,361.154,364.196,370.244,376.292,382.34,385.382,387.632,389.441,393.986,397.028,401.069,405.11,409.655,414.2,418.745,425.288,429.833,432.128,434.378,436.187,443.234,447.779,451.82,454.367,456.914,461.459,463.709,465.518,470.063,474.104,477.65,480.197,483.239,487.784,491.825,494.372,496.919,501.464,506.009,508.304,510.554,512.363,516.404,520.949,525.494,527.744,529.553,534.098,538.139,542.684" svgx:width="0.5,0.33,0.44,0.28,0.5,0.25,0.55,0.5,0.44,0.33,0.33,0.28,0.44,0.33,0.25,0.55,0.33,0.67,0.67,0.67,0.33,0.25,0.55,0.5,0.33,0.44,0.44,0.5,0.5,0.5,0.72,0.5,0.25,0.25,0.55,0.78,0.5,0.44,0.28,0.28,0.5,0.25,0.55,0.5,0.44,0.39,0.28,0.33,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.44,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">brain barrier (BBB) breakdown, myelin destruction, and neu-</text>
   <text y="637.083" x="310.016,313.058,317.603,322.148,326.189,328.736,331.616,336.161,340.202,344.747,348.788,353.333,357.374,360.416,364.457,367.004,369.551,374.096,378.641,380.936,383.321,389.864,394.409,396.956,399.503,404.048,408.593,413.138,417.683,420.563,425.108,429.149,433.694,436.241,439.283,443.324,445.871,448.418,452.459,456.5,459.047,461.594,466.139,470.684,473.564,478.109,481.151,484.031,489.08,494.624,502.67,509.213,513.758,520.301,523.181,527.222,531.767,536.312,538.859,543.404,545.654" svgx:width="0.33,0.5,0.5,0.44,0.28,0.25,0.5,0.44,0.5,0.44,0.5,0.44,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.72,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.25,0.5,0.44,0.5,0.28,0.33,0.44,0.28,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.56,0.61,0.89,0.72,0.5,0.72,0.25,0.44,0.5,0.5,0.28,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ronal degeneration. Antibody neutralization of SEMA4D could, </text>
   <text y="648.081" x="310.016,312.563,317.108,321.149,324.191,328.232,331.274,335.819,338.861,342.902,345.197,347.447,353.522,357.563,364.61,368.651,371.198,373.745,378.29,381.332,385.373,387.92,391.961,394.211,400.286,407.333,411.878,414.425,416.972,419.519,424.064,426.611,430.652,432.902,438.977,442.523,446.564,449.111,453.152,456.194,460.739,464.285,466.832,470.378,472.628,478.703,481.25,485.795,488.837,493.382,497.927,502.472,507.017,509.267,515.342,522.389,526.934,529.481,532.028,534.575,539.12,541.667,545.663" svgx:width="0.28,0.5,0.44,0.33,0.44,0.33,0.5,0.33,0.44,0.25,0.25,0.55,0.44,0.78,0.44,0.28,0.28,0.5,0.33,0.44,0.28,0.44,0.25,0.55,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.55,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.55,0.28,0.5,0.33,0.5,0.5,0.5,0.5,0.25,0.55,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">therefore, ameliorate multiple sclerosis through multiple </text>
   <text y="659.079" x="310.016,317.063,321.104,325.145,329.69,333.731,338.276,340.823,344.369,351.416,354.962" svgx:width="0.78,0.44,0.44,0.5,0.44,0.5,0.28,0.39,0.78,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">mechanisms.</text>
   <text y="670.077" x="310.016,317.018,322.022,325.019,329.015,333.011,336.008,338.51,343.01,347.006,350.507,353.504" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="670.077" x="355.898,361.901,364.403,368.903,372.899,377.399,379.901,384.401,388.901,391.295,396.299,401.798,409.799,416.297,420.797,427.295,429.689,433.685,438.185,442.685,445.187,449.687,452.081,456.581,459.578,464.078,471.08,475.58,478.082,482.078,484.472,488.972,491.474,494.309,497.306,501.302,504.299,508.295,512.795,515.297,517.799,521.795,524.297,526.799,531.299,535.799,538.193,542.693,545.69" svgx:width="0.67,0.28,0.5,0.44,0.5,0.28,0.5,0.5,0.25,0.56,0.61,0.89,0.72,0.5,0.72,0.25,0.44,0.5,0.5,0.28,0.5,0.25,0.5,0.33,0.5,0.78,0.5,0.28,0.44,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Blocking SEMA4D could promote differentiation of </text>
   <text y="681.075" x="310.016,314.516,317.018,319.52,324.02,328.52,333.02,337.016,341.516,346.016,349.013,353.513,357.509,362.009,364.511,368.507,370.757,371.954,376.454,379.451,383.447,387.443,391.943,394.94,398.441,402.941,405.938,409.439,411.689,412.886,416.882,421.382,425.882,428.132,429.329,432.326,436.322,443.324,447.824,451.82,454.322,456.824,461.324,465.32,467.822,470.324,474.824,479.324,481.574,483.824,485.021,488.018,492.518,494.768,495.965,499.961,504.461,508.961,511.463,513.965,516.467,520.967,525.467,527.717,529.967,531.164,535.664,538.661,542.657" svgx:width="0.5,0.28,0.28,0.5,0.5,0.5,0.44,0.5,0.5,0.33,0.5,0.44,0.5,0.28,0.44,0.25,0.55,0.5,0.33,0.44,0.44,0.5,0.33,0.39,0.5,0.33,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.33,0.44,0.78,0.5,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.33,0.5,0.25,0.55,0.44,0.5,0.5,0.28,0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.5,0.33,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">oligodendrocyte precursors and remyelination. In addition, pre-</text>
   <text y="692.073" x="310.016,314.516,318.512,323.012,325.514,328.016,332.516,337.016,339.185,344.189,349.688,357.689,364.187,368.687,375.185,378.182,385.184,389.18,393.68,396.182,400.178,402.68,406.676,411.176,413.345,417.845,420.842,424.838,428.834,433.334,437.834,442.334,448.832,453.332,455.501,460.001,462.998,465.167,467.669,472.169,476.165,478.334,482.834,485.336,489.836,494.336,498.836,501.005,505.505,508.502,512.498,515.0,519.5,521.669,526.169,530.165,533.162,536.159,538.661,542.657,545.654" svgx:width="0.5,0.44,0.5,0.28,0.28,0.5,0.5,0.25,0.56,0.61,0.89,0.72,0.5,0.72,0.33,0.78,0.44,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.5,0.33,0.44,0.44,0.5,0.5,0.5,0.72,0.5,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.5,0.28,0.5,0.5,0.5,0.25,0.5,0.33,0.44,0.28,0.5,0.25,0.5,0.44,0.33,0.33,0.28,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">venting SEMA4D-mediated breakdown of the blood brain barrier </text>
   <text y="703.071" x="310.016,313.013,319.016,325.019,331.022,334.019,336.269,337.205,344.207,348.203,352.703,354.953,355.889,359.39,363.89,368.39,372.89,375.887,379.883,383.384,386.885,389.135,390.071,392.573,399.575,406.577,411.077,415.577,419.573,421.823,422.759,426.755,430.751,433.253,435.755,438.005,438.941,441.443,445.943,448.94,451.442,453.944,456.446,459.443,463.439,465.941,468.443,472.943,477.443,479.693,480.629,483.131,487.631,490.133,494.633,496.883,497.819,500.321,504.821,508.817,511.067,512.003,518.006,524.504,529.508,531.758,532.694,536.69,541.19,545.69" svgx:width="0.33,0.67,0.67,0.67,0.33,0.25,0.55,0.78,0.44,0.5,0.25,0.55,0.39,0.5,0.5,0.5,0.33,0.44,0.39,0.39,0.25,0.55,0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.55,0.44,0.44,0.28,0.28,0.25,0.55,0.28,0.5,0.33,0.28,0.28,0.28,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.67,0.72,0.56,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(BBB) may suppress immune cell infiltration into the CNS and </text>
   <text y="714.069" x="310.016,313.013,317.009,321.509,326.009,330.005,334.001,336.251,337.529,340.031,344.531,347.528,350.03,354.026,361.028,368.03,372.026,374.528,377.03,381.53,386.03,388.28,389.558,393.554,398.054,402.554,404.804,406.082,409.583,413.579,417.575,422.075,426.575,431.075,435.071,438.068,442.568,444.818,446.096,448.598,455.6,462.602,467.102,471.602,475.598,477.848,479.126,482.123,486.119,489.62,494.12,498.62,503.12,506.621,510.617,514.118,516.368,517.646,520.148,524.648,526.898,528.176,534.179,540.677,545.681" svgx:width="0.33,0.44,0.5,0.5,0.44,0.44,0.25,0.55,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.39,0.44,0.44,0.5,0.5,0.5,0.44,0.33,0.5,0.25,0.55,0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.55,0.33,0.44,0.39,0.5,0.5,0.5,0.39,0.44,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.67,0.72,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">reduce inflammation and secondary immune responses to CNS </text>
   <text y="725.067" x="310.016,314.012,318.512,321.014,323.516,328.016,332.012,336.512,340.013" svgx:width="0.44,0.5,0.28,0.28,0.5,0.44,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">antigens.</text>
  </g>
 </g>
</svg>
